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Stress exposure is known not only to be a risk factor for the 
development of psychiatric disorders itself, but also to exacerbate other 
medical conditions, prompting structural and functional changes that 
can eventually evolve from a normal adaptive body reaction to a 
pathological state (Gradus, 2017).  
On this basis, the aim of my PhD project was to investigate at preclinical 
level how and by which molecular mechanisms stress exposure can 
leave a signature in the individual, thus increasing the susceptibility of 
the central nervous system (CNS) to stress-related disorders or 
aggravating the outcome of illnesses occurring later in life. To achieve 
this goal, I took advantage of a “double hit” approach that implies that a 
‘first hit’, mostly during critical periods of development, disrupts the 
ontogeny of neural systems and establishes a vulnerability to a ‘second 
hit’ later in life. Among the multiple mechanisms involved in stress-
susceptibility, I have focused my analyses on neuroplasticity, 
neuroinflammation and oxidative damage. Moreover, considering that 
one of the most crucial variables of stress response extent is when the 
individual experiences it, I have investigated the long-lasting impact of 
stress occurring in different time windows. 
Specifically, I firstly focused on the gestational period, a so-called 
“window of vulnerability” (Briscoe et al., 2016) since the exposure to 
adverse events during pregnancy has been shown to impact not only on 
maternal health but also to have a deep long-lasting influence on the 
offspring neurodevelopment, leading to enhanced susceptibility to 
diseases and dysfunctions during adulthood (Zucchi et al., 2013; Coe 
and Lubach, 2005; Entringer et al., 2015). Therefore, in the first part of 
my project I examined the long-term effects of stress occurring during 
the intrauterine life on the clinical manifestations of a well-established 
animal model of multiple sclerosis, the Experimental Autoimmune 
Encephalomyelitis (EAE), a chronic and inflammatory condition 
characterized by loss of myelin (Robinson et al., 2014). My results 
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demonstrated that gestational stress induced a marked increase in the 
severity of EAE symptoms in the adult mouse. Further, I highlighted an 
altered maturation of oligodendrocytes in the spinal cord of prenatally 
stressed EAE animals. These behavioral and molecular alterations were 
paralleled by changes in the expression and signaling of the 
neurotrophin BDNF, an important mediator of neural plasticity that may 
contribute to stress-induced impaired remyelination (Murray and 
Holmes, 2011).  
Furthermore, since patients affected by stress-related disorders present 
deficit in the neuroplastic mechanisms that are normally set in motion in 
response to external challenging stimuli (Wang et al., 2017), I 
investigated the influence of stress in utero on the response to a second 
challenge in adulthood, exposing prenatally stressed mice to a further 
acute stress. The molecular analyses in the hippocampus revealed that 
fetal stress resulted not only in increased activation of the immune 
system itself, but also in an impairment of the proper responsiveness of 
the redox machinery to the second stress. 
I then focused on adolescence, a sensitive period for brain development 
and thus also for environmental stimuli including stress. Social stress, 
such as bullying or subordination, is among the most prevalent 
stressors throughout adolescence and is strongly related to an 
enhanced susceptibility to diseases and dysfunctions later in adulthood 
(Lupien et al., 2009). Moreover, adolescents are more prone to brain 
concussion, and indeed 15/19-year age juvenile are experiencing the 
highest rates of incidence of traumatic brain injury (TBI) (Kimbler et al., 
2011). As such, I spent 6 months as a visiting PhD student at the 
laboratory of Brain Injury, Neuroinflammation and Cognitive Function 
headed by Professor Susanna Rosi at the University of California, San 
Francisco, to investigate if and how exposure to social stress during 
adolescence can alter the TBI outcome. Specifically, in this part of the 
PhD project, adolescent mice were exposed to the social defeat stress 
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protocol before being injured with a new model of TBI, the repetitive 
closed-head impact model of engineered rotational acceleration 
(CHIMERA). The results highlighted that stressed mice developed 
anxiety-like features, regardless the concussions, while stress and brain 
injury have a reciprocal influence in the NOR test, where only mice that 
were both stressed and exposed to TBI did not display impairment in 
the ability to recognize the novel object. Paralleled to these behavioral 
effects, we didn’t find differences in hippocampal microglia activation. 
Lastly, I have investigated stress exposure during adulthood, focusing 
on the potential long-lasting impact of a chronic stress paradigm -known 
to induce psychiatric-like phenotype in preclinical model- in altering the 
responsiveness to a second acute challenge after a recovery period of 3 
weeks. The molecular analyses, focused on modulators of the oxidative 
balance, demonstrated that the second hit was able to strongly induce 
the gene expression of Sulfiredoxin 1 (Srxn1) and Metallothionein-1a 
(Mt-1a), two antioxidant genes. This beneficial effect set in motion to 
cope with the sudden challenging situation was impaired by the 
previous exposure to chronic stress. Interestingly, chronic treatment 
with the antipsychotic lurasidone partially restored the appropriate acute 
responsiveness.  
 
The results obtained during my PhD project by using the double hit 
approach in different periods of life, indicate neuroinflammation, altered 
oxidative balance and impaired neuroplasticity as common molecular 
targets underlying the impact of a previous stress in shaping the 
vulnerability to further adverse conditions, providing new information on 
the etiopathogenesis of stress-related diseases.  
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“Ogni stress lascia un’indelebile cicatrice, l’organismo paga questo 
diventando un po’ più vecchio dopo una situazione di stress” H.Selye, 
1956 
 
Vivere esperienze stressanti, anche apparentemente innocue, può 
incidere fortemente sul nostro equilibrio omeostatico e avere diverse 
conseguenze patologiche, nell’eventualità il nostro corpo non reagisca 
in maniera fisiologica e adattativa. Lo stress è, infatti, un noto fattore di 
rischio per lo sviluppo di patologie psichiatriche e non. 
A tal riguardo, lo scopo della mia tesi di dottorato è stato studiare come 
-e attraverso quali meccanismi molecolari- un evento stressante possa 
lasciare una “traccia” nell’individuo, predisponendolo così ad una 
maggiore suscettibilità verso condizioni patologiche che possono 
successivamente verificarsi. Le mie analisi si sono concentrate su 
alcuni noti bersagli molecolari dello stress, come ad esempio 
meccanismi di neuroplasticità, neuroinfiammazione e stress ossidativo. 
Inoltre, siccome l’età in cui si fa esperienza di forti stress è una tra le 
variabili che condizionano maggiormente le conseguenze dello stress 
stesso, ho focalizzato i miei studi su 3 diverse finestre temporali: il 
periodo perinatale, l’adolescenza e l’età adulta. 
Nella prima parte del mio progetto ho approfondito il ruolo dello stress 
durante la gestazione (stress in utero), un periodo estremamente 
sensibile a stimoli esterni tanto da essere nominato “finestra di 
vulnerabilità”. Vi sono infatti diverse evidenze scientifiche che 
dimostrano come eventi avversi durante questa finestra temporale 
possano avere conseguenze di lunga durata, non solo sulla salute 
materna ma anche della progenie, aumentando così il rischio che i 
nascituri possano sviluppare disfunzioni patologiche una volta adulti. 
Più in dettaglio, ho studiato gli effetti a lungo termine dell’esposizione a 
stress prenatale sul decorso dell’encefalomielite autoimmune 
sperimentale (EAE), un modello preclinico avvalorato di sclerosi 
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multipla caratterizzato a sua volta da danno mielinico, che è stato 
indotto in topi da esperimento nati da madri stressate una volta adulti. I 
risultati ottenuti dimostrano che la precedente esposizione a stress 
peggiora significativamente la sintomatologia dell’encefalomielite. 
Abbiamo inoltre evidenziato una compromessa maturazione degli 
oligodendrociti a livello del midollo spinale degli animali 
precedentemente esposti a stress. Come possibile meccanismo 
sottostante abbiamo quindi ipotizzato che lo stress agisca sul signaling 
della neurotrofina BDNF, nota avere un ruolo neuroprotettivo, e di 
conseguenza comprometta il processo fisiologico di riparazione del 
danno mielinico.  
Nella seconda parte del mio progetto ho invece analizzato un’altra 
potenziale conseguenza a lungo termine dello stress in utero, cioè 
come questo possa influenzare la capacità di risposta ad un secondo 
stress acuto. In individui sani, la normale risposta ad uno stress 
improvviso prevede la messa in modo di meccanismi adattativi basati 
sulle proprietà plastiche neuronali. Tuttavia, queste proprietà sono note 
essere alterate in soggetti affetti da malattie psichiatriche legate allo 
stress. Ho quindi sottoposto topi stressati prenatalmente ad un secondo 
stress acuto, più precisamente al paradigma di nuoto forzato. Le analisi 
condotte hanno poi evidenziato che la precedente esposizione a stress 
non solo modifica il grado d’infiammazione basale degli animali, ma per 
di più altera la normale responsività acuta di sistemi come quello del 
bilancio ossidativo che vengono fisiologicamente attivati in risposta a 
stress improvvisi.  
Mi sono successivamente focalizzata sull’adolescenza, un altro periodo 
estremamente sensibile a stimoli ambientali come lo stress. Fenomeni 
di stress sociale come bullismo o subordinazione sono frequenti 
durante questa fascia d’età e possono predisporre gli adolescenti ad 
una maggiore vulnerabilità a sviluppare patologie e disfunzioni. Il terzo 
obiettivo della mia tesi è stato quindi valutare come stress sociali 
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durante questo periodo possano creare un substrato più sensibile ad 
altre esperienze molto frequenti durante l’adolescenza, come la 
concussione cerebrale a seguito di sport o incidenti. Ho lavorato a 
questo progetto presso il laboratorio di Brain Injury, Neuroinflammation 
and Cognitive Function, University of California, San Francisco sotto la 
supervisione della Professoressa Susanna Rosi, che studia diversi 
modelli di trauma cranico. Più nello specifico ho utilizzato il paradigma 
di social defeat stress come modello di stress sociale su topi 
adolescenti che successivamente hanno subito due concussioni di 
moderata entità, che ho indotto avvalendomi di un modello 
recentemente sviluppato di trauma (repetitive closed-head impact 
model of engineered rotational acceleration (CHIMERA). Ho poi 
analizzato l’attivazione di cellule microgliali, noti target sia dello stress 
che del trauma cranico, nell’ippocampo. 
Infine, nella quarta sezione di questo lavoro ho utilizzato un modello di 
stress cronico da immobilizzazione per 4 settimane in ratti adulti. 
Questo paradigma di stress cronico è usato a livello sperimentale per 
indurre sintomi simili a quelli sviluppati da pazienti affetti da malattie 
psichiatriche legate allo stress. Per il mio progetto, ho esaminato come 
uno stress cronico in età adulta possa lasciare una “traccia”, che rimane 
anche dopo 3 settimane di recupero quando invece i sintomi simil-
psichiatrici si sono risolti, capace di alterare la risposta ad un secondo 
episodio acuto di immobilizzazione. Le mie analisi si sono concentrate 
su alterazioni a carico del sistema redox, il cui ruolo nell’eziologia delle 
malattie psichiatriche è ormai riconosciuto, e sulle proprietà 
terapeutiche e antiossidanti dell’antipsicotico lurasidone. 
 
In conclusione, per questo progetto di tesi mi sono avvalsa di diversi 
approcci sperimentali per analizzare approfonditamente come uno 
stress, specialmente se vissuto in momenti sensibili della vita, possa 
rendere l’individuo più vulnerabile a successivi eventi avversi. I risultati 
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che ho ottenuto evidenziano come alterazioni a carico di sistemi di 
neuroplasticità, infiammazione e bilancio ossidativo possano essere 
meccanismi messi in moto dallo stress per lasciare questa “traccia” di 
suscettibilità.  
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1. Introduction 
 
1.1 Stress as environmental risk factor for different diseases 
 
Environmental challenges are part of everyday life. Since most people 
are, at some point, exposed to physical or psychological stress events -
such as loss of a dear one, violence, severe diseases diagnosis or 
natural disasters– carrying out adaptive mechanisms to face the 
stressful experience is a major priority. As a consequence, the body has 
developed an efficient set of connected biological systems to maintain 
homeostasis even in the most demanding situations. This “adaptive” 
machinery recruits several systems including, but not confined to, the 
autonomic nervous system (ANS), the hypothalamus pituitary 
adrenocortical axis (HPA), the metabolic and the immune system. 
Hans Selye (1907–1983) is credited to be the first scientist who 
introduced the concept of stress in his theory of the “General Adaptation 
Syndrome” (1936). Selye postulated that stress response consists in a 
series of three stages: (1) alarm reaction, in which epinephrine and 
glucocorticoids are released to restore homeostasis; (2) resistance, in 
which defense and adaptation are sustained; and if the stress persists,  
(3) exhaustion, the consequence of which can be damaging. Selye’s 
theories have been reinterpreted over the years and the concept of 
“allostasis” has been introduced (McEwen, 1998). Allostasis is defined 
as the adaptive process by which stability and homeostasis are 
achieved, and the price the body has to pay to maintain this stability as 
a reaction to physical and psychological challenges is called “allostatic 
load”. While many mechanisms involved in allostasis are beneficial for 
the individual, others can render the organism more sensitive or 
susceptible to new challenges. Thus, when the cost to adaptation is 
excessive and exceeds the supplies, the body is facing an “allostatic 
overload” that can predispose individuals to illness. As a result, this 
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maladaptive response to stress has been strongly associated to a 
plethora of diverse diseases, some related to the psychiatric realm and 
others affecting different human body systems. 
Trauma and stress-related psychiatric diseases -such as major 
depressive disorder (MDD), generalized anxiety disorder, post-traumatic 
stress disorder (PTSD), acute stress disorder and adjustment disorder- 
are a family of psychiatric diseases that arise following a stressful or 
traumatic event (Manual of Mental Disorders, DSM-5). Indeed, as other 
mental illnesses, stress-related mood disorders are known to result from 
a complex gene x environment interaction (GxE), in which the 
combination of a vulnerable genetic background and environmental risk 
factors -specifically stress- may contribute to their etiology (Sharma et 
al., 2016; Assary et al., 2018).  
Furthermore, stress represents a risk and triggering factor for disorders 
that target different systems such as hypertension, ischemic heart 
diseases, heart failure, stroke and other cardiovascular diseases (Sara 
et al., 2018, Fioranelli et al., 2018), diseases of the gastrointestinal tract 
(Konturek et al., 2011; Bernstein, 2017), osteoporosis (Kelly et al., 
2019), metabolic diseases such as diabetes (Harris et al., 2017; Kelly 
and Ismail, 2015), neurodegenerative diseases (Justice, 2018; 
Sotiropoulos, 2015) and demyelinating diseases such as Multiple 
Sclerosis (Briones-Buixassa et al., 2015; Riise et al., 2011). 
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Gene x Environment interaction (adapted from Caspi and Moffitt, 2006) 
 
 
1.1.1 Stress response variability 
As described above, the switch between allostatic load and overload is 
a complex and finely regulated process influenced by multiple factors. 
Some of these variables rely directly to the stressor itself (e.g., intensity, 
duration and type) and others are inherent to the individual (e.g., 
genetic background, biological age of exposure, social economic status 
and the capacity to cope with stress). As a result, mechanisms set in 
motion and final outcomes are strikingly distinct across individuals. 
Among the mentioned variables, in my PhD project I focused 
specifically on the time at which the stressful event occurs.  
Preclinical and clinical studies have shown that early phases of life are 
particularly sensitive to stress, probably because the brain undergoes 
such important changes during these periods. In particular, the 
gestational period is a so-called “window of vulnerability” (Briscoe et al., 
2016) and the exposure to adverse events during pregnancy has been 
shown to impact not only on maternal health but also to have a deep 
long-lasting influence on the offspring neurodevelopment, leading to an 
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enhanced susceptibility to diseases and dysfunctions during adulthood 
(Zucchi et al., 2013; Coe and Lubach, 2005; Entringer et al., 2015).  
Adolescence is another vulnerable time of many psychosocial and 
physiological changes, including how an individual responds to 
stressors. Specifically, adolescence is marked by significant shifts in 
hypothalamic-pituitary-adrenal (HPA) axis reactivity, resulting in 
heightened stress-induced hormonal responses (Romeo, 2013).  
 
Besides the evidences demonstrating the actual role of stress in the 
etiology and pathogenesis of such diseases, the underlying molecular 
mechanisms are still not elucidated. It is therefore relevant to 
investigate how and through which molecular systems and pathways 
the exposure to stressful experiences can influence so crucially several 
illnesses.  
  
14 	
1.2 Molecular mechanisms of stress response 
 
To understand how stress can contribute to illness development, it is 
primary to consider the mechanisms set in motion to adapt to stressful 
situations and to investigate how these initially positive and protective 
adjustments can become harmful for the body. 
Hallmarks of stress response are the activation of the autonomic 
nervous system and of the hypothalamic-pituitary-adrenal (HPA) axis. In 
response to a stressor -paralleled by the activation of the sympathetic 
nervous system that affects several peripheral organs, including the 
adrenal medulla that releases epinephrine- the hypothalamus secretes 
the corticotropin-releasing hormone CRH, which induces the synthesis 
and release of the adrenocorticotropic hormone (ACTH) from the 
anterior pituitary. ACTH then stimulates the release of corticosteroids 
(cortisol in human and corticosterone in rodents) that bind to their 
mineralocorticoid (MR) and glucocorticoid (GR) receptors and thus 
initiate/terminate the HPA axis stress response, via the negative 
feedback, and modulate acquisition processing, storage and retrieval of 
stressful experiences (Sapolsky et al., 2000). As a result, proper 
activation of the HPA-axis affects brain functioning to ensure adaptation 
to the stressor, but stress-induced mal-adaptation of the HPA-axis 
functionality may provide a mechanistic basis for stress-induced illness 
vulnerability. 
Initiation of the stress response is not limited to activation of the ASN 
and HPA axis. Indeed, stress has been strongly associated with 
alterations of other mechanisms including neuroplasticity, immune 
response and redox homeostasis.  
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1.2.1 Neuroplasticity 
The term neuroplasticity was used for the first time by Santiago Ramon 
y Cajal (1852-1934) (Ramón y Cajal, 1913-1914)  and now referred to 
“the fundamental ability to make adaptive changes related to the 
structure and function of the nervous system” (Fuchs and Flugge, 
2014). The molecular and cellular mechanisms underlying processes 
such as learning and memory are the best-characterized and most 
studied examples of neural plasticity. Stress is known to significantly 
influence learning and memory in a type, duration, and intensity of the 
stressor dependent way. It is generally assumed that short periods of 
stress can potentiate memory formation via synaptic plasticity -and this 
is likely to be the reason of long-term memories formation after 
traumatic events- whereas more severe or prolonged stressors can 
have deleterious effects upon learning and memory, leading even to 
amnesia, and upon several other aspects of cognition, both in human 
and in rodents (Joels et al., 2006; Shors, 2006; Anacker and Hen, 
2017). Long-term potentiation (LTP) -an electrophysiological 
phenomenon of increase in synaptic strength produced by trains of 
stimuli- is one of the principal form of brain plasticity and one of the 
underlying processes of learning and memory. Over the past decades, it 
has been demonstrated that stress can lead to alterations of 
hippocampal LTP, following the inverted U-shaped dose effect fashion 
(Joels et al., 2006). Indeed, while exposure to stress-induced 
glucocorticoids in term of minutes to hours, such as what happens 
during an acute stress, is associated with enhanced LTP (Wang et al., 
2019), prolonged periods of stress impair LTP functions (Joels and 
Krugers, 2007). 
Among all the molecular regulators of neuronal plasticity, neurotrophic 
factors (NTFs), and in particular the neurotrophin family, are key players 
and are known to support survival, differentiation and maintenance of 
neuronal functions and finely modulate all the crucial steps of network 
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construction (Poo, 2001). The neurotrophin family comprises of nerve 
growth factor (NGF), Brain-derived neurotrophic factor (BDNF), 
neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4) that have all evolved 
from a common neurotrophin ancestor gene. Their actions are 
dependent on binding to transmembrane receptor systems, the 
tropomyosin receptor tyrosine kinase family and the p75 neurotrophin 
receptor (Chao and Hempstead, 1995). 
BDNF is a key mediator of activity-dependent processes and helps 
neurons to adapt and survive and speeds up the brain’s ability to make 
new connections. The link between stress and BDNF is well recognized 
(McEwen et al., 2015) and to date, various animal models of stress 
have shown that negative stressors can affect neuroplasticity through 
altering Bdnf expression in the brain. For example, studies where 
rodents were exposed to early life stress, chronic stress or acute stress 
have significantly reduced Bdnf expression in different brain regions 
(Molteni et al., 2016; Luoni et al., 2016; Molteni et al., 2009; Bondar and 
Merkulova, 2016). 
 
1.2.2 Neuroinflammation 
Large body of evidence indicates that stress can activate inflammatory 
response both at peripheral and central level (Rohleder, 2014; Calcia et 
al., 2016). Both pro-inflammatory and anti-inflammatory mechanisms 
depend on the type, intensity and duration of stressors. Indeed, 
activation of the immune system is physiological when a stress is 
perceived, so that the body can be ready to react to possible injuries 
and infections subsequent to it, but can be detrimental when the stress 
is prolonged and mismanaged.  
The immune system is composed of two interconnected branches. The 
first one is called innate immunity, is the body’s first line of defence 
against tissue damage and microbial infection (Medzhitov, 2007). The 
effector cells of innate immunity constantly circulate in the body and 
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detect a wide variety of pathogens. These cells are able to signal the 
occurrence of injuries or infections and initiate a cascade of 
inflammatory processes that help contain an infection and promote 
healing and recovery (Medzhitov, 2007) When the innate immune 
defences are insufficient, these cells activate the second branch of the 
immune system, called adaptive immunity (Barton, 2008). In contrast to 
innate immunity, which is non-specific and does not confer long-lasting 
protection to the host, adaptive immunity involves the proliferation of 
specific white blood cells, such as lymphocytes, that attempt to 
neutralize or eliminate the intruders based on an immunological 
memory. Within the central nervous system (CNS), microglia cells are 
the key immune players and acquire a reactive profile to cope with 
altered homeostasis (Hanisch and Kettenmann, 2007), mainly by 
increasing the expression of pro-inflammatory mediators and 
neurotoxins (Reader et al., 2015; Ramirez et al., 2017). 
In the past years it has been shown that excessive inflammation directly 
contribute to pathophysiology of stress-related diseases. Indeed, 
preclinical models of stress paradigm known to induce psychiatric-like 
symptoms are associated with up-regulated expression of pro-
inflammatory cytokines as well as microglia over-activation in stress-
sensitive brain regions (Rossetti et al., 2016; Wang et al 2018; 
Hohmann et al., 2017, Weber et al., 2017, Stein et al., 2017). 
 
1.2.3 Oxidative Stress 
A further feature of stress response is the dysregulation of the redox 
balance and resultant oxidative stress. Oxidative stress -the imbalance 
between cellular production of reactive oxygen species and the 
counteracting antioxidant mechanisms- has been proposed to play 
several roles in the pathogenesis of chronic-degenerative conditions, 
such as athero-thrombotic events, neurodegeneration, cancer, some 
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forms of anemia, auto-immune diseases, and the entire comorbidity of 
uremia and diabetes (Galli et al., 2005). 
Furthermore, several evidences link oxidative stress and mental 
disorders. One hypothesis for this association could be that the brain, 
besides it represents only a small portion of the total body weight, 
accounts for 20% of the overall energy expenditure in resting conditions 
and this high energy and oxygen demand, coupled with the unsaturated 
lipid enrichment, render it highly susceptible to redox unbalance (Cobley 
2018). Interestingly, reactive oxygen species (ROS) are essential for 
neuronal signaling and function and are involved in several cellular 
processes, although they become detrimental when their production is 
excessive. Hence, the unbalance of the redox state due to increased 
production of ROS and/or the failure of antioxidant detoxifying 
mechanisms has been suggested to be a common pathogenic 
mechanism underlying many major psychiatric disorders. Evidences 
supporting this hypothesis come from clinical (Hassan et al., 2016; 
Salim, 2014; Ng et al., 2008; Schiavone et al., 2013) and preclinical 
studies. Specifically, using different experimental stress models, it has 
been demonstrated that paradigms such as chronic stress (Rossetti et 
al., 2018), acute stress (Casaril et al., 2019; Spiers et al., 2013), social 
defeat (Gao et al., 2019; Bouvier et al., 2017) or CORT treatment (Chen 
et al., 2019) can results in increased levels of pro-oxidant enzymes, lipid 
peroxidation and impairments of the antioxidant machinery. 
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Molecular targets of stress  
 
 
1.3 Stress-based experimental models 
 
Despite animal models are not able to fully recapitulate human 
pathologies, especially considering the complexity, the multifaceted 
symptoms and the neurobiology of stress-related disorders, they 
represent a relevant tool for advancing our comprehension of the 
mechanisms underlying specific aspects of such diseases. In general, 
for the scientific community there are three main criteria for judging 
whether a particular model is properly useful to investigate a specific 
disease or condition: the construct, the face and the predictive validity. 
Construct validity refers to how well the mechanisms used to induce the 
disease phenotype in animals reflects the currently understood disease 
etiology in humans: the researchers should recreate in an animal the 
etiologic processes that cause a disease in humans and thus replicate 
the neural and behavioral features of the illness; face validity indicates 
that a model recapitulates important anatomical, biochemical, 
neuropathological, or behavioral features of a human disease whereas 
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predictive (or pharmacological) validity signifies that a model responds 
to treatments in a way that predicts the effects in humans.  
In my project I took advantage of three well-established model of stress 
exposure: the prenatal stress, the social defeat stress and the chronic 
restraint stress. 
 
1.3.1 Prenatal Stress 
As mentioned before, the perinatal period is a critical time window when 
the so-called “fetal programming” occurs (Barker, 1998; Kwon and Kim, 
2017). The theory of fetal programming proposes that the environment 
surrounding the fetus during its development plays a seminal role in 
determining its disease risk during the later stages. Indeed, in support of 
this, a growing amount of evidence from human and non-human studies 
shows that maternal stress during pregnancy exerts pervasive, long-
lasting effects on the development of the fetal nervous system and, 
ultimately, on the offspring's physiology and behavior (Frasch et al., 
2018). At molecular level, prenatal stress (PNS) has been associated 
with priming of the immune system and exacerbated response to 
inflammatory challenges in adulthood (Diz-Chaves et al., 2013) as well 
as impaired neural plasticity (Boersma et al., 2014). In preclinical 
studies, the most commonly used paradigm of prenatal stress consists 
in restraining pregnant dams in different phases of gestation with 
simultaneous exposure to a bright light (Weinstock, 2016). 
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Schematic representation of prenatal stress paradigm 
 
 
1.3.2 Social Defeat Stress 
The social defeat paradigm uses social conflict between members of 
the same species to generate emotional and psychological stress and 
thus triggering depression-like behaviors -in particular social avoidance- 
as well as cognitive impairment (Hollis and Kabbaj, 2014; McKim et al., 
2016). These behavioral derangements are associated with increased 
oxidative stress and inflammation (Patki et al., 2013) and impaired 
neuroplasticity (Blugeot et al., 2011). A widely used protocol of social 
defeat consists in introducing the experimental rodent into the home 
cage of an older, aggressive, dominant male. The intruder is quickly 
attacked and forced into subordination for the remaining of the physical 
interaction. The defeat experience, however, is not only a physical 
stressor. After a brief physical exposure and attack, intruders are often 
placed in a protective cage for the remaining of the test, allowing for 
psychogenic exposure to the resident without physical harm (Golden et 
al., 2011).  
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Schematic representation of social defeat paradigm 
 
 
1.3.3 Chronic Restraint Stress 
The use of restraint or immobilization for investigations of animal 
physiology, pathology and pharmacology has an extensive history (Paré 
and Glavin, 1986). Restraint is a preferred means of stressing animals, 
largely because it is straightforward, painless and without lasting 
debilitation. Indeed it doesn’t involve any bodily harm to the animal 
subject once the period of the restraint is terminated. This ensures that 
any long-term effects of stress observed are due to the stressor that 
was applied, rather than to the physical repercussions of an irreversible 
or chronic injury. Immobilization can be acute or chronic, and with 
sessions lasting from 15/30 minutes to several hours (Paré and Glavin, 
1986). Exposure to chronic restraint stress have been shown to induce 
depressive and anxiety-like phenotypes (Chiba et al., 2012) as well as 
cognitive deficits coupled by decreased BDNF levels in the 
hippocampus (Zhang et al., 2017), activation of the immune system at 
central level (Calcia et al., 2016) and oxidative stress (Salehi et al., 
2018). 
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Schematic representation of a restrainer 
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2. Aim of the project 
 
Stress is part of our everyday life. As a result, human natural selection 
has shaped a well and carefully orchestrated body response that relies 
on different system –including the autonomic nervous system and the 
HPA axis- to properly react to threats. An adequate response is 
therefore crucial to adapt to environmental changes that occur in 
different developmental stages throughout life. When the coping 
strategies set in motion after being exposed to a challenge are not 
sufficiently effective, the risk of maladaptive response increases. As a 
consequence, stress is known to be a crucial environmental component 
for the etiology of psychiatric diseases (Schmitt et al., 2014) but also to 
be an exacerbating risk factor for several diseases and conditions 
(Salleh, 2008). 
With these premises, the overall goal of my PhD project was to deepen 
the mechanisms by which a previous stress exposure can prime and 
predispose the individual to be more vulnerable and prone to overreact 
when adverse conditions occur later in life. To achieve this result, my 
strategy has been to take advantage of different preclinical paradigms 
of stress and investigate how they create a “susceptible substrate” for 
further adverse challenges and diseases. Specifically, since time is one 
most crucial variable that influence stress response and consequences, 
I decided to focus on three specific time windows: early life, 
adolescence and adulthood. I then analyzed molecular systems known 
to be stress-sensitive-such as neuroplasticity, inflammatory activation 
and oxidative balance- in region of the CNS that are known to mediate 
molecular and behavioral features of stress response. 
The first aim of the project was to evaluate the impact of a prenatal 
stress exposure on the susceptibility to the experimental autoimmune 
encephalomyelitis (EAE), a demyelinating condition of the CNS that 
resemble some feature of multiple sclerosis (MS). The contribution of 
environmental factors such as stress in prompting MS or influencing its 
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manifestations and course is not clearly elucidated (Heesen et al., 
2007) and the few preclinical studies that have been carried out are 
focused on the long-term effects of neonatal manipulations (Krementsov 
and Teuscher, 2013; Teunis et al., 2002; Columba-Cabezas et al., 
2009, Case et al., 2010). Therefore this study is -to the best of our 
knowledge- the first elucidating the impact of gestational stress. Our 
analyses were addressed to the neurotrophin BDNF, theorized to have 
a neuroprotective function in myelin repair, evaluating if prenatal stress 
affects myelination acting on this molecule and its signaling. 
Secondly, since one of the features of stress-related disorders 
symptomatology is the impairment in neuroplastic mechanisms that are 
normally orchestrated to react to a new challenge or threat (Wang et al., 
2017), the second objective of the project was to investigate the 
influence of stress in utero on the response to a second challenge in 
adulthood. More in detail, I exposed mice born from mothers stressed 
during pregnancy to a further acute stress, and investigate how the 
previous stress exposure influenced the physiological acute 
responsiveness of inflammatory markers and mediators of the oxidative 
balance. 
Adolescence is known be another time window peculiarly sensitive to 
the environment (Jaworska and MacQueen, 2015). Specifically, 
psychosocial stress, such as bullying or subordination, is strongly 
related to an enhanced susceptibility to diseases and dysfunctions later 
in adulthood (Lupien et al., 2009). Therefore, the third aim of my project 
was to investigate how social stress can influence the final outcome of 
another high-incidence experience of adolescents, such as brain 
concussion. I worked on this project during the 6 months that I spent as 
a visiting PhD student at the laboratory of Brain Injury, 
Neuroinflammation and Cognitive Function headed by Professor 
Susanna Rosi at the University of California, San Francisco. More in 
detail, I exposed adolescent male mice to the social defeat stress 
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protocol and then gave them mild concussions using a recently 
developed experimental model of traumatic brain injury (TBI), the 
repetitive closed-head impact model of engineered rotational 
acceleration (CHIMERA). My analyses were then focused on the 
behavioral consequences of this combined condition and on the role of 
microglia, the resident immune cells of the brain, known to a be a key 
player in both stress and TBI-induced neuroinflammation. 
To achieve the fourth and last objective of my project I took advantage 
of a well-established animal model of stress-related psychiatric 
diseases, the chronic restraint (CRS) paradigm, known to induce 
psychiatric-like phenotypes in experimental animals (Chiba et al., 2012). 
I examined how chronic stress during adulthood can leave a molecular 
signature that is still present, even after the animal recovers from the 
depressive-like behavioral derangements. To unmask such molecular 
signature, three weeks after the end of CRS, I exposed the rats to an 
acute stress and investigate whether the animal acute responsiveness 
could be altered by the previous stress exposure. I focused my 
molecular analyses on modulators of the oxidative balance, recognized 
to have a role in the etiology of mental diseases, and on the protective 
therapeutic role of the antipsychotic lurasidone. 
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3. Materials and Methods 
 
3.1 Experimental paradigms 
 
3.1.1 Experiment 1: Prenatal stress and EAE induction 
 
Animals 
Adult female C57BL/6 pregnant mice at gestational day (GD) 14 were 
purchased from a commercial breeder (Charles River, France). Upon 
arrival, the animals were singly housed with food and water freely 
available and were maintained on a 12-h light/dark cycle in a constant 
temperature (22 ± 2oC) and humidity (50 ± 5%) conditions. All animal 
experiments were conducted according to the authorization from the 
Health Ministry n.1136/2016PR in full accordance with the Italian 
legislation on animal experimentation (DL 26/2014) and adherent to EU 
recommendation (EEC Council Directive 2010/63). All efforts were 
made to minimize animal suffering and to reduce the number of animals 
used. 
 
Experimental conditions and stress procedure 
Ten pregnant dams were randomly selected for exposure to restraint 
stress, from GD16 until delivery. Briefly, the animals were subjected to 
two (GD16 and GD17) or three (GD18 and GD19) daily stress sessions 
at 10.00 a.m. and 14.00 p.m. (GD16 and GD17) or 9.30 a.m., 12.30 
p.m. and 15.30 p.m. (GD18 and GD19), during which they were placed 
in plastic cylinders (12cm long and 4cm diameter) for 45 minutes under 
bright light (3000 lux). The control pregnant females were left 
undisturbed in their home cages in the same room where the stress was 
performed. At weaning (post-natal day 21, PND21) female pups were 
selected from control and stressed mothers and subjected to one of four 
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experimental conditions: (i) mice born from non-stressed dams-
NOPNS/CTRL (n=12), (ii) mice born from non-stressed dams exposed 
to the EAE model-NO PNS/EAE (n=15), (iii) mice born from stressed 
dams-PNS/CTRL (n=15), (iv) mice born from stressed dams exposed to 
EAE-PNS/EAE (n=16). All animals were socially housed (n=4 per cage) 
under standard laboratory conditions.  
 
Experimental Autoimmune Encephanomyelitis (EAE) 
EAE was induced in 8-week-old female by subcutaneous immunization 
in the flanks and in the tail base with 300 µg of myelin oligodendrocyte 
glycoprotein (MOG35-55, Espikem) per mouse in IFA (Sigma Aldrich) 
supplemented with 8 mg/ml of Mycobacterium tuberculosis (strain 
H37Ra, Difco). Mice immunized received 500 ng of pertussis toxin 
(PTX, Duotech) intravenously the day of the immunization and 48 h 
later. Animals were daily weighted and scored for clinical symptoms of 
EAE according the following scale: 0 = healthy, 1 = flaccid tail, 2 = 
ataxia and/or paresis of hindlimbs, 3 = paralysis of hindlimbs and/or 
paresis of forelimbs, 4= tetraparalysis, 5 =moribund or death. Non-EAE 
controls received PTX injections, as well as the initial injections of 
emulsion but without the encephalitogen, to ensure that observed 
effects are due to EAE and not to reactions to the ancillary components 
used to facilitate disease induction. At PND106/ day post injection 50, 
all the animals were sacrificed and the spinal cord was dissected for 
molecular analyses. 
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Schematic representation of the experimental paradigm 
 
 
3.1.2  Experiment 2: Prenatal stress and acute stress 
 
Animals 
Adult female C57BL/6 pregnant mice at gestational day (GD) 14 were 
purchased from a commercial breeder (Charles River, France). Upon 
arrival, the animals were singly housed with food and water freely 
available and were maintained on a 12-h light/dark cycle in a constant 
temperature (22 ± 2oC) and humidity (50 ± 5%) conditions. All animal 
experiments were conducted according to the authorization from the 
Health Ministry n.1136/2016PR in full accordance with the Italian 
legislation on animal experimentation (DL 26/2014) and adherent to EU 
recommendation (EEC Council Directive 2010/63). All efforts were 
made to minimize animal suffering and to reduce the number of animals 
used. 
 
Experimental conditions and stress procedure 
Ten pregnant dams were randomly selected for exposure to restraint 
stress, from GD16 until delivery. Briefly, the animals were subjected to 
two (GD16 and GD17) or three (GD18 and GD19) daily stress sessions 
at 10.00 a.m. and 14.00 p.m. (GD16 and GD17) or 9.30 a.m., 12.30 
GD16 
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p.m. and 15.30 p.m. (GD18 and GD19), during which they were placed 
in plastic cylinders (12cm long and 4cm diameter) for 45 minutes under 
bright light (3000 lux). The control pregnant females were left 
undisturbed in their home cages in the same room where the stress was 
performed.  
At weaning (post-natal day 21, PND21) male pups were selected from 
control and stressed mothers and to one of four experimental 
conditions: i) mice born from non-stressed dams not exposed to acute 
stress-NO PNS/NO AS, (ii) mice born from non stressed mice exposed 
to acute stress and sacrificed after 5 minutes-NOPNS/AS 5’, (iii) mice 
born from non stressed mice exposed to acute stress and sacrificed 
after 2 hours-NOPNS/AS 2h, (iv) mice born from stressed dams not 
exposed to acute stress-PNS/NO AS, (v) mice born from stressed mice 
exposed to acute stress and sacrificed after 5 minutes-PNS/AS 5’, (vi) 
mice born from stressed mice exposed to acute stress and sacrificed 
after 2 hours-PNS/AS 2h. All animals were socially housed (n=4 per 
cage) under standard laboratory conditions.  
AS groups, once adult (PND90) were exposed to an acute stress, the 
Forced Swim Stress, for 6 minutes, during which the mice were placed 
in a tank with a capacity of 2L, filled with water in a way that the animals 
were not able to touch the bottom of the tank, either with their feet or tail 
or jump out of it. 
 
 
 
 
Schematic representation of the experimental paradigm  
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3.1.3 Experiment 3: Social defeat stress and 2rTBI 
 
Animals 
Adolescent male C57BL/6J mice at 3 weeks of age were purchased 
from the Jackson Laboratory. Mice were given one week of acclimation, 
individually housed with a reversed 12-hour light – 12-hour dark cycle 
and provided food and water ad libitum. 
 
Experimental conditions and stress procedure 
At 4 weeks, mice were randomly assigned to one of the following group: 
(i) mice not exposed to the social defeat paradigm without injury-No 
Stress/sham (n=10), (ii) mice not exposed to the social defeat paradigm 
that received the repetitive concussion-No Stress/rTBI (n=10), (iii) mice 
stressed with the social defeat paradigm without injury-Stress/sham and  
(n=12) (iv) mice stressed with the social defeat paradigm that received 
the repetitive concussion-Stress/rTBI (n=12). 
Mice from group iii and iv were exposed to the social defeat stress for 
10 consecutive days. In each daily session the test mice was exposed 
an older, aggressive, dominant sex-matched mouse (CD1, Charles 
River) for 10 minutes. In details, the experimental mouse was placed in 
the home cage of the dominant mouse. After the 10 minutes stress, 
mice were left in the same cage with the aggressor but separated by a 
perforated plexiglass divider to allow only sensory contact for 24 hours. 
Control (non-stressed) animals were pair housed in cages with one 
mouse per side of the perforated divider. All control mice were rotated 
daily, similarly to mice undergoing defeat, but without physical contact 
with their cage mates. 
All animal experiments were conducted in compliance with animal 
protocols approved by the Institutional Animal Care and Use Committee 
at the University of California, San Francisco (UCSF), following the 
National Institutes of Health Guidelines for animal care.  
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Closed-Head Impact Model of Engineered Rotational Acceleration 
(CHIMERA) repetitive brain injury 
Experimental repetitive mild traumatic brain injury (rTBI) was induced in 
6 weeks old mice using the Closed-Head Impact Model of Engineered 
Rotational Acceleration (CHIMERA) TBI model. The animals were 
anesthetized using isoflurane (2%) in oxygen 1L/minute during the 
procedure. rTBI animals were subjected to 2 mild closed head injuries 
using the CHIMERA device as previously reported (Namjoshi et al., 
2017). Briefly, rTBI animals were placed supinely into an angled holding 
platform without any shaving of the head or incision into the skin so that 
their head was level with the piston target hole while aligning the eyes, 
ears and nose such that the impact was centered on the dorsal 
convexities of the skull, targeting a 5 mm area surrounding bregma. A 
nose cone delivering isoflurane was removed just prior to the impact. 
Impact was initiated using Real Term software that was connected to a 
system including air tank, pressure regulator, digital pressure gauge, 
two-way solenoid valve, and piston. The impact was administered using 
an air pressure of 2.95 PSI, resulting in an impact energy of 0.5 J from 
the 5 mm, 50 g piston. Animals were moved to an incubator 
immediately after the impact and monitored until fully recovered. rTBI 
animals received an injury once per day for 2 days with a 24 hour 
interval in between impacts. Sham mice were exposed to the same 
isoflurane anesthesia paradigm (~ 8 minutes of anesthesia in total) 
without sustaining an impact. All animals regained the righting reflex in 
5 minutes or less. Skull fractures, seizures, apnea or mortality were not 
observed in any animals, and no animals were excluded from the study 
due to injury parameters. 
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Schematic representation of the CHIMERA apparatus 
 
 
 
 
Schematic representation of the experimental paradigm 
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3.1.4 Experiment 4: Chronic restraint stress and acute stress 
 
Animals 
Adult male Sprague-Dawley rats (Charles River, Italy) were brought into 
the laboratory two weeks before the start of the experiment. Rats were 
housed with food and water freely available and were maintained on a 
12-h light/dark cycle, socially housed (n=3/4 per cage) in a constant 
temperature (22 ± 2oC) and humidity (50 ± 5%) conditions. All 
procedures used in this study have conformed to the rules and 
principles of the 2010/63/UE Directive, according to the authorizations 
from the Health Ministry n 151/2017-PR.  
 
Experimental conditions and stress procedure 
After two weeks of adaptation to laboratory and housing conditions, rats 
were randomly selected for exposure to chronic restraint stress (CRS) 
and divided in the following experimental groups: i) naive animals, 
treated with saline and not exposed to acute stress-No Stress/VEH/NO 
AS (n=10); ii) naïve animals, treated with saline exposed to acute 
stress-No stress/VEH/AS (n=10); iii) naïve animals, chronically treated 
with lurasidone not exposed to acute stress-No Stress/LUR/NO AS 
(n=10); iv) naïve animals, treated with lurasidone and exposed to acute 
stress-No Stress/LUR/AS (n=10); v) stressed animals, treated with 
saline not exposed to acute stress-CRS/VEH/NO AS (n=10); vi) 
stressed animals, treated with saline exposed to acute stress-
CRS/VEH/AS (n=10); vii) stressed animals, chronically treated with 
lurasidone not exposed to acute stress-CRS/LUR/NO AS (n=10); viii) 
stressed animals, treated with lurasidone and exposed to acute stress-
CRS/LUR/AS (n=10). 
CRS rats were exposed to an unpredictable chronic restraint stress for 
4 weeks. Rats were placed in plastic cylinders for 1 hour two times/day 
at random hours, to avoid habituation. The dimensions of the restrainer 
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were similar to the size of the animal, which made the animal almost not 
able to move. Control rats were left undisturbed in their home cages in 
the same room where the stress was performed. At the end of the 
stress procedure, all the animals were left undisturbed for three weeks 
of recovery (washout). Following the washout period, rats were exposed 
to one hour of acute restraint stress (AS). 
 
 
 
Schematic representation of the experimental paradigm 
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3.2 Behavioural tests  
 
Nest building assessment (Experiment 1) 
The nest building assessment test was performed to investigate 
changes in the well-being of the animals. Raw material (nesting paper) 
was provided to all the pregnant females and, the day after the birth, the 
complexity of the nest has been scored by four different blind operators 
according to the following scale: 0 = the animal has not manipulated the 
building material; 1 = the material has been manipulated but the 
position of the nest is not clear (sparse paper on the bottom of the 
cage); 2 = flat nest, without vertical walls; 3 = "cup" nest with walls less 
than half the height of a nest with a full dome; 4 = nest with incomplete 
dome; 5 = nest with full dome. 
 
Elevated Plus Maze (Experiment 3) 
Animals were tested 7 days post injury using an elevated plus-shaped 
maze, raised 40 cm above the floor in a room with bright lighting. The 
surface of the maze consisted of two closed arms opposite to each 
other (30.5 cm in length) enclosed in black plastic. The other two 
perpendicular arms were open (35 cm in length) with white lights 
illuminating the open arms. Mice were placed in the center (4.5 cm 
square) of the maze and allowed to explore for 5 minutes while their 
location and activity were recorded. The maze was cleaned with 70% 
ethanol between animals. The time in the open area (which included 
time both in the open arms and center which is uncovered) was 
recorded and scored using a video tracking and analysis setup 
(Ethovision XT 8.5, Noldus Information Technology). Mice that fell off 
the maze during testing were excluded from analysis. 
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Schematic representation of Elevated Plus Maze apparatus 
 
 
Novel Object Recognition (Experiment 3) 
Mice were tested for NOR 3 week post injury. An open arena (30 cm × 
30 cm×30 cm; L×W×H) was placed in a dimly lit behavior test room with 
an overhead camera. The mice were allowed to explore the open arena 
for 10 min for two consecutive days. On day 3, two identical objects 
were placed in the arena and mice were allowed to explore for 5 min. 
On day 4, one of the objects was replaced by a novel one and mice 
were allowed to explore for 5 min. Exploratory behavior was defined as 
the animal directing its nose toward an object at a distance less than 2 
cm. Objects were secured in the arena with magnets. Arena and objects 
were wiped with 70 % ethanol between trials to eliminate odor cues. 
Trials were recorded by the overhead camera and analyzed by an 
automatic video tracking system (EthoVision, Noldus) for movement 
tracking and by manual scoring for exploratory behavior. Discrimination 
index was calculated using the formula: (time exploring novel object − 
time exploring familiar object)/total exploring time. 
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Schematic representation of Novel Object Recognition test 
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3.3 Molecular Analyses 
 
Molecular analyses were conducted in the cervical portion of the spinal 
cord (Exp 1) in the hippocampus (Exp 2, Exp 3 and Exp 4) of the 
experimental animals.  
 
3.3.1 RNA preparation and gene expression analyses 
For gene expression analyses, total RNA was isolated from CNS 
samples by single step guanidinium isothiocyanate/phenol extraction 
using PureZol RNA isolation reagent (Bio-Rad Laboratories S.r.l.; 
Segrate, Italy) according to the manufacturer’s instructions and 
quantified by spectrophotometric analysis. The samples were then 
processed for real-time polymerase chain reaction (PCR) as previously 
reported (Rossetti et al., 2018). Briefly, an aliquot of each sample was 
treated with DNAse to avoid DNA contamination and subsequently 
analyzed by TaqMan qRT-PCR instrument (CFX384 real-time system, 
Bio-Rad Laboratories S.r.l.) using the iScript one-step RT-PCR kit for 
probes (Bio-Rad Laboratories S.r.l.). Samples were run in 384-well 
format in triplicate as multiplexed reactions with a normalizing internal 
control (β-actin). Thermal cycling was initiated with incubation at 50 °C 
for 10 min (RNA retrotranscription), and then at 95 °C for 5 min 
(TaqMan polymerase activation). After this initial step, 39 cycles of PCR 
were performed. Each PCR cycle consisted of heating the samples at 
95 °C for 10 sec to enable the melting process, and then for 30 sec at 
60 °C for the annealing and extension reactions. A comparative cycle 
threshold (Ct) method was used to calculate the relative target gene 
expression versus the control group. Specifically, fold change for each 
target gene relative to β-actin was determined by the 2-Δ(ΔCT) method, 
where ΔCT = CT,target – CT, β -actin and Δ(ΔCT) = CT, exp. group - 
CT, control group and CT is the threshold cycle. For graphical clarity, 
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the obtained data were then expressed as percentage versus control 
group, which has been set at 100%.  
 
 
Table 1: Sequences of forward and reverse primers and probes used in 
Real-time PCR analyses and purchased from Eurofins MWG-Operon 
and probes purchased from Life Technologies, which did not disclose 
the sequences.  
  
Gene Forward primer Reverse primer Probe 
β-Actin CACTTTCTACAATGAGCTGCG CTGGATGGCTACGTACATGG TCTGGGTCATCTTTTCACGGTTGGC 
Arc GGTGGGTGGCTCTGAAGAAT ACTCCACCCAGTTCTTCACC GATCCAGAACCACATGAATGGG 
cFOS TCCTTACGGACTCCCCAC CTCCGTTTCTCTTCCTCTTCAG TGCTCTACTTTGCCCCTTCTGCC 
Tgf-β GCTGGCAGTAGCTCCCCTATTT  
TTGAGGTTGAGGGAGAAAGCAG 
 
GTGGTATACTGAGACACCTTGGTGTC 
 
BDNF 
iso IV 
AGCTGCCTTGATGTTTACTTTG 
 
CGTTTACTTCTTTCATGGGCG 
 
AGGATGGTCATCACTCTTCTCACCTGG 
 
Long 
BDNF  
GTTGTCATTGCTTTACTGGCG 
 
AATTTTCTCCATCCCTACTCCG 
 
AATCTACCCCTCCCATTCCCCGT 
 
BDNF 
iso VI 
GGACCAGAAGCGTGACAAC 
 
ATGCAACCGAAGTATGAAATAACC 
 
ACCAGGTGAGAAGAGTGATGACCATCC 
 
Total 
BDNF 
AAGTCTGCATTACATTCCTCGA 
 
GTTTTCTGAAAGAGGGACAGTTTAT 
 
TGTGGTTTGTTGCCGTTGCCAAG 
 
	
Gene Assay ID   
Il-1β Mm00434228_m1   
Tnf-α Mm00443258_m1   
Il-6 Mm00446190_m1   
Nrf2 Rn00582415_m1   
Gpx1 Rn00577994_g1   
Gpx4 Rn00820816_g1   
Mt-1α Rn00821759_g1   
Srxn1 Rn04337926_g1   
Nox2 Rn00675098_m1   
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3.3.2 Protein extraction and western blot analyses 
CNS samples were manually homogenized using a glass-glass potter in 
a pH 7.4 cold buffer (containing 0.32 M sucrose, 1 mM MgCl2, 1mM 
NaHCO3, 10 mM HEPES solution, and 0.1 mM 
phenylmethylsulfonyfluoride in presence of a complete set of proteases 
[Roche] and phosphatase [Sigma-Aldrich] inhibitors) and then sonicated 
for 10 seconds at a maximum power of 10% to 15% (Bandelin 
Sonoplus). The homogenate was clarified (1000 g; 10 minutes), 
obtaining a pellet (P1) enriched in nuclear components, which was 
resuspended in a buffer (20 mM HEPES, 0.1mM dithiothreitol, 0.1 mM 
EGTA) supplemented with protease and phosphatase inhibitors. The 
supernatant (S1) was then centrifuged (13000g; 15 minutes) to obtain a 
clarified fraction of cytosolic proteins (S2). The pellet (P2), 
corresponding to the crude membrane fraction, was resuspended in the 
same buffer used for the nuclear fraction. Total protein content was 
measured according to the Bradford Protein Assay procedure (Bio-Rad 
Laboratories), using bovine serum albumin (BSA) as calibration 
standard.  
Equal amounts of protein (ranging from 10 to 17 ug) were run under 
reducing conditions on polyacrylamide gels and then electrophoretically 
transferred onto nitrocellulose membranes. Unspecific binding sites 
were blocked with 10% nonfat dry milk; then the membranes were 
incubated overnight with the primary antibodies and for1 or 2 hours at 
room temperature with a peroxidase-conjugated anti-rabbit or anti-
mouse IgG. Immunocomplexes were visualized by chemiluminescence 
using the ECL ETA C 2.0 (Cyanagen) or ECL SUN (Cyanagen). Results 
were standardized using β-actin as the internal control, which was 
detected by evaluating the band density at 43 kDa. Protein levels were 
calculated by measuring the optical density of the immunocomplexes 
using chemiluminescence (Chemidoc MP Imaging System, Bio-Rad 
Laboratories). To ensure that autoradiographic bands would be in the 
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linear range of intensity, different exposure times were used. 
 
3.3.3 Immunohistochemistry 
Experiment 1 
Three animals from each experimental condition were dedicated to 
immunofluorescence staining. Mice were anesthetized with ketamine 
(100 mg/kg)/xylazine (10 mg/kg) and perfused transcardially with 0,1 M 
EDTA (Sigma Aldrich) in saline followed by 4% neutral buffered formalin 
(Sigma Aldrich) in deionized water. Spinal cords were collected and 
post-fixed for 1 hour in the same solution at 4°C, cryoprotected in 30% 
sucrose for 24 hours, embedded in OCT and then frozen at -80°C. 
Spinal cords were cut transversally into 20 µm-thick sections with a 
cryostat and processed for immunofluorescence. Slides were incubated 
for 45 minutes at room temperature with a blocking solution composed 
by 10% normal goat serum and 0.1% triton X-100 in phosphate buffered 
saline (PBS). Then, the sections were incubated with rabbit polyclonal 
anti-GPR17 (1:2500, custom antibody produced by PRIMM, Milan, Italy) 
overnight at 4°C in PBS with 5% goat normal serum and 0.1% Triton X-
100. Following primary antibody incubation, the sections were washed 
and incubated with the biotinylated secondary antibody (Vector Labs, 
Burlingame, USA) for 1 hr at room temperature. GPR17 labeling was 
detected with the high sensitivity tyramide signal amplification kit (Perkin 
Elmer, Milan, Italy) according to the manufacturer’s instruction. Hoechst 
33528 was used to visualize cell nuclei. After processing, sections were 
mounted on microscope slides with fluorescent mounting medium 
(Dako, Milan, Italy).  
For each animal 2 sections from the cervical spinal cord were entirely 
acquired at 10X magnification and reconstructed with Adobe Photoshop 
CC. In each section GPR17 positive cells were counted in the whole 
white matter. 
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Experiment 3 
After sacrifice, one brain hemisphere from each experimental mouse 
was immediately put into 4% PFA at 4° C, fixed overnight and then 
switched into 30% sucrose solution for at least two days. Hemibrains 
were then embedded in a 2:1 30% Sucrose/OCT solution, frozen in 
isopentane and stored at -80°C. Samples were sliced into 20 µm 
coronal sections with a cryostat and then processed for 
immunofluorescence. Slices were incubated for 30 minutes at room 
temperature with a TSA-BB blocking solution and then incubated with 
rabbit anti-Iba1 (1:400, Wako Pure Chemicals) overnight at 4°C in TSA-
BB. Following primary antibody incubation, sections were washed and 
incubated with AF-568 goat anti-rabbit secondary antibody (1:400, Life 
Technologies). DAPI was used for nuclear counterstaining. After 
processing, sections were mounted on microscope slides with ProLong 
mounting medium (ThermoFisher). Images from hippocampal 
regionCA1 were taken using a Zeiss Imager Z1 under a 20x objective 
lens. The area of Iba1+ signal was measured in ImageJ. 
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Table 2: Conditions of the antibodies used in western blot analyses and 
immunohistochemistry analyses (O/N: over/night; RT: room 
temperature).  
  
Protein Primary antibody Secondary antibody 
β-ACTIN (43 KDa) 1:10000 1h RT (Sigma) anti-mouse 1:10000 1h RT 
NRF-2 (100KDa) 1:500 O/N 4°C (R&D Systems) anti-mouse 1:1000 2h RT 
IL-10 (24 kDa) 1:1000 O/N 4°C (GeneTex) anti-rabbit 1:1000 1h RT 
PRX-SO3 (22 kDa) 1:2000 O/N 4°C (abcam) anti-rabbit 1:2000 1h RT 
mBDNF (14 kDa) 1:500 O/N 4°C (Icosagen) anti-mouse 1:1000 1h RT 
pAKT (60 kDa) Ser473 1:1000 O/N 4°C (Cell signaling) anti-rabbit 1:2000 1h RT 
AKT (60 kDa) 1:1000 O/N 4°C (Cell signaling) anti-rabbit 1:1000 1h RT 
pmTOR (260 kDa) Ser2448 1:1000 O/N 4°C (Cell signaling) anti-rabbit 1:1000 1h RT 
mTOR (260 kDa) 1:1000 O/N 4°C (Cell signaling) anti-rabbit 1:1000 2h RT 
MAG (100 kDa) 1:1000 O/N 4°C (Cell signaling) anti-rabbit 1:1000 1h RT 
GPR17  1:2500 O/N 4°C (PRIMM) anti-rabbit 1:1000 2h RT 
Iba-1 1:400 O/N 4°C (Wako Pure Chemicals) anti-rabbit 1:400 2h RT 
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3.4 Statistical Analyses  
3.4.1 Behavioral Results 
 
Experiment 1 
Analyses of body-weight gain -of the mothers and of the pups before 
and after the EAE induction- and EAE clinical score were performed 
with Two-way analysis of variance (ANOVA) with repeated measures. 
Comparisons between stressed animals or non stressed mice in nest 
building assessment test score, number of pups, ratio between female 
and male newborn and day of the EAE onset were analyzed by two-
tailed Unpaired t test. 
 
Experiment 2 
Analysis of body-weight gain was performed with Two-way analysis of 
variance (ANOVA) with repeated measures.  
 
Experiment 3 
Analyses of time spent in the open arms and center (EPM) and of the 
discrimination index (NOR) were performed with Two-way analysis of 
variance (ANOVA) followed -when appropriate- by a Single Contrast 
Post Hoc Test (PLSD). Significance for all was assumed for P<0.05. 
Data are presented as means ± SEM.  
 
3.4.2 Molecular Results 
For exp 1, 2 and 3, the paradigm effects on the mRNA and protein 
levels or the signal density of the molecular targets were evaluated with 
a Two-way ANOVA followed -when appropriate- by a Single Contrast 
Post Hoc Test (PLSD). 
In exp 1, differences in the GPR17 positive cell count and MAG protein 
levels were evaluated using two-tailed Unpaired t test.  
In exp 4, the three-way ANOVA with PLSD was used to investigate the 
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effect of chronic restraint stress (NoStress/CRS), of the 
pharmacological treatment (VEH/LUR) and of the acute restraint 
challenge (No Stress/AS), as independent factors.  
Significance for all was assumed for P<0.05. Data are presented as 
means ± SEM.  
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4. Results 
 
4.1 Prenatal stress reshapes spinal myelination affecting BDNF 
signaling in the experimental autoimmune encephalomyelitis 
model of multiple sclerosis.  
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4.1.1 Introduction 
 
Stress experience has been consistently established to be a major 
environmental factor in the etiology of several neurological and 
psychiatric diseases (Gradus, 2017). Thus, living stressful situations 
can lead to several molecular alterations that can eventually evolve 
from a normal adaptive body reaction to a medical condition (Davis et 
al., 2017). This different trajectory may depend on several variables 
such as the genetic background of the subject, the socio-economic 
context, the nature, severity and duration of the stressful experience 
and the time when the stress occurs. In particular, the gestational period 
is a so-called “window of vulnerability” (Briscoe et al., 2016) and the 
exposure to adverse events during pregnancy has been shown to 
impact not only on maternal health but also to have a deep long-lasting 
influence on the offspring neurodevelopment, leading to an enhanced 
susceptibility to diseases and dysfunctions during adulthood (Zucchi et 
al., 2013; Coe and Lubach, 2005; Entringer et al., 2015). Underlying this 
effect named “fetal programming” (Barker, 1998; Kwon and Kim, 2017) 
it has been hypothesized that prenatal stress (PNS) can leave a 
signature in the progeny by affecting neural plasticity. In line with this 
hypothesis, prenatal stress exposure has been associated to alterations 
of the neurotrophin Brain-derived neurotrophic factor (BDNF), a crucial 
player in neurodevelopment and neuronal plasticity known to be 
involved in several neurodegenerative and psychiatric diseases (Autry 
and Monteggia, 2012; Zuccato and Cattaneo, 2009). For example, PNS 
has been found to reduce BDNF gene expression in the amygdala and 
hippocampus of rats at weaning and during adulthood (Boersma et al., 
2014), to increase BDNF (exon IV) DNA methylation in the medial 
prefrontal cortex of adult male rats (Blaze et al., 2017), and to decrease 
the neurotrophin protein levels in the hippocampus of both female and 
male rats (Yeh et al., 2012). Of note, changes in BDNF expression were 
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also found in the spinal cord of prenatally stressed adult rats (Winston 
et al., 2014). Even though the more robust evidences for BDNF 
modulation by early life stress derive from preclinical studies, it has 
been also reported in humans that maternal experiences of chronic 
stress -such as war trauma- are associated with alterations of BDNF 
methylation in both newborn and maternal tissues (Kertes et al., 2017) 
and the level of the neurotrophin in the amniotic fluid during pregnancy 
is positively correlated to maternal early adversity exposure (Deuschle 
et al., 2018). 
On these bases, the aim of our study was to investigate the potential 
long-lasting impact of PNS exposure on the susceptibility to pathologies 
known to be characterized by alterations of neural function and 
plasticity, such as multiple sclerosis (MS), an autoimmune disease 
whose incidence is greatly increasing among young individuals, starting 
from adolescents (GBD 2016 Multiple Sclerosis collaborators). The 
contribution of environmental factors such as stress in prompting MS or 
influencing its manifestations and course is not clearly elucidated 
(Heesen et al., 2007). Specifically, little is known about the mechanisms 
by which adverse events during -or around- the gestation period may 
increase the susceptibility to MS in the progeny. Indeed, to the best of 
our knowledge, only few clinical studies have linked MS risk with 
features of maternal behavior including breastfeeding duration 
(Ragnedda et al., 2015; Conradi et al., 2013), delivery mode (Maghzi et 
al., 2012; Nielsen et al., 2013) or vitamin D intake (Mirzaei et al., 2011). 
In this regard only one report indicating a possible -but not statistically 
significant- association between stressors, such as late prenatal 
maternal care and maternal illness during pregnancy, and MS has been 
published so far (Gardener et al., 2009). At preclinical level, most 
studies using the experimental autoimmune encephalomyelitis (EAE) 
mouse -the most commonly model for MS- are focused on the long-term 
effects of neonatal manipulations (Krementsov and Teuscher, 2013; 
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Teunis et al., 2002; Columba-Cabezas et al., 2009, Case et al., 2010) 
but the influence of stress during gestation on EAE has not yet been 
investigated. 
With these premises, the aim of this study has been to evaluate the 
impact of a prenatal stress exposure on EAE course at adulthood. 
Specifically, given that MS affects women twice as often as men (Harbo 
et al., 2013), we induced EAE in the female adult progeny of dams 
exposed to a stressful manipulation during the last days of gestation 
and we scored the clinical symptoms in comparison with un-stressed 
cohorts. Moreover, in order to clarify the molecular mechanisms 
underlying the stress effect, specific molecular analyses have been 
performed in the spinal cord. In particular, given the demyelinating 
nature of the encephalomyelitis, we first focused our analyses on 
markers of different stages of olygodendrocyte maturation and 
thereafter on the upstream Akt/mTOR signaling pathway, relevant for 
myelination itself, pinpointing the neurotrophin BDNF as a potential 
player in the long-lasting influence of PNS on EAE development and 
MS vulnerability. 
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4.1.2 Results 
 
4.1.2.1 Behavioral Results 
 
4.1.2.1.1 Impact of stress exposure on dams and female offspring 
To establish whether restraint stress exposure affects proper gestation 
course, starting from GD17 until the 38th day post-partum, we monitored 
the body weight of control and stressed pregnant mice as well as their 
capability to build a nest, using the nest test as an indicator of animal 
wellbeing. As shown in figure 1, no difference in the body-weight profile 
(Fig.1A) or in the nest complexity (Fig.1B) was found between stressed 
and control dams. Likewise, we did not observe significant changes in 
the number of pups per litter or in the sex ratio (Fig.1C, D). 
Subsequently, to establish the lasting effects of prenatal stress (PNS) 
also in the offspring after weaning, we monitored the weight of female 
pups from PND 24 to PND 56, finding that early stress reduced the 
body weight of female pups born from stressed dams compared to their 
non-stressed littermates (F1,56= 25.78, P<0.001; Fig.1E). 
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Fig.1 Impact of stress exposure on dams and female offspring 
(A) Body weight of pregnant control (NO PNS) and stressed (PNS) 
dams measured during gestational stress and up to 38 days after 
delivery. (B) Score of the complexity of the nests built by control and 
stressed mothers and assessed the day after delivery. (C) Total number 
of pups and (D) ratio between male and female pups born from control 
and stressed mothers. (E) Body weight of female pups born from control 
and stressed mothers monitored from PND 24 to PND 56.  
For all the analyses the data are expressed as mean of the examined 
variable ± SEM of independent determinations. *P<0.05, ***P<0.001 vs. 
NO PNS (Two-way ANOVA with Fisher’s LSD). 
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4.1.2.1.2 Long-term effect of prenatal stress exposure on EAE 
clinical signs and course 
To assess whether PNS could affect EAE course and severity, EAE 
female pups were daily weighted and scored using the 0-5 grading 
system for clinical assessment from day post-immunization (DPI) 1 to 
DPI 50. The clinical profile of EAE symptoms is reported in figure 2, 
where the body weight changes (Fig.2A) and disability score (Fig.2C) 
during the four phases of EAE progression -onset, acute phase, 
recovery and chronic phase- are shown. The statistical analysis 
indicated that pups born from stressed dams weighted less than their 
littermates in the acute phase of the clinical signs development (F1,26 = 
4.979, P<0.05). It is noteworthy that PNS reduced also the body weight 
of non-immunized control mice throughout adulthood (F1,25= 15.05 
P<0.001; Fig.2B). Furthermore, clinical manifestations of EAE in 
prenatally stressed mice were enhanced as compared to the control 
EAE group as displayed by the increased EAE score over time, 
especially during the acute phase (F1,22 = 4.630, P<0.05) and the 
following recovery phase (F1,22 = 7.667, P<0.05). The cumulative 
disease score (CDS) was also higher in the PNS/EAE group (P=0.0662; 
Fig.2D). No difference was observed in the day of onset and in the 
maximum score (CS max) (Fig.2E, F). Taken together, these behavioral 
results provide clear evidences that PNS enhances the susceptibility to 
develop a more severe EAE in the female offspring.  
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Fig.2 Long-term effect of prenatal stress exposure on EAE clinical signs 
and course 
(A) Body weight and (C) clinical score of EAE animals monitored from 
DPI 0 to DPI 50 throughout the 4 phases of EAE course (onset, acute 
phase, recovery, chronic phase). (B) Body weight of non-immunized 
control and stressed animals from DPI 0 to DPI 44. (D) Cumulative 
disease score CDS, (E) day of EAE symptoms onset and (F) maximum 
score, CS max in prenatally stressed and non-stressed EAE mice. For 
all the analyses the data are expressed as mean of the examined 
variable ± SEM of independent determinations. *P<0.05, **P<0.01, 
***P<0.001 vs. NO PNS/CTRL; @P<0.05 vs. NO PNS/EAE (Two-way 
ANOVA with Fisher’s LSD). 
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4.1.2.2 Molecular Results 
 
4.1.2.2.1 Analyses of GPR17 and MAG in the Spinal Cord 
To gain insight into potential molecular alterations underlying the 
exacerbated EAE symptomatology observed in mice prenatally exposed 
to stress, we first analyzed two markers of different stages of 
oligodendrocytes maturation in the cervical spinal cord: GPR17, a 
receptor expressed by early oligodendrocyte precursor cells (OPCs) 
and a key modulator of OPC maturation and myelination (Fumagalli et 
al., 2015) and MAG, a myelin-associated glycoprotein expressed by 
mature and differentiated oligodendrocytes. 
The count of GPR17 positive cells (GPR17+) in the whole white matter 
of the cervical spinal cord highlighted a greater number of OPCs in EAE 
animals prenatally exposed to stress compared to non-stressed EAE 
mice (+30% vs. NO PNS/EAE, P<0.01), as summarized in figure 3, 
showing reconstructed spinal cord sections of NO PNS/EAE and 
PNS/EAE mice (Fig.3A) and the numbers of GPR17 positive cells 
(Fig.3B). Consistently, immunoblot results showed a strong decrease of 
MAG only in stressed EAE animals (P<0.01; -51% vs. NO PNS/EAE, 
P<0.05; Fig.3C), suggesting altered remyelination in the chronic phase 
of EAE progression and a higher reaction of OPCs that do proliferate, 
but fail in reaching terminal maturation. 
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Fig.3 Analyses of GPR17 and MAG in the spinal cord 
(A) Reconstructed spinal cord sections of NO PNS/EAE and PNS/EAE 
mice. GPR17 positive cells (GPR17+) were counted in the whole white 
matter of the cervical spinal cord (B) whereas MAG protein levels were 
investigate using western blot analysis (C). GPR17+ counting data are 
expressed as mean of the examined variable ± SEM of independent 
determinations. MAG protein levels are expressed as a percentage of 
non-stressed EAE mice (NO PNS/EAE, set at 100%) and represent the 
mean ± SEM of independent determinations. @P<0.05, @@P<0.01 vs. 
NO PNS/EAE (Unpaired t test). 
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4.1.2.2.2 Analysis of BDNF/Akt/mTOR signaling 
Among the several players involved in the complex process of OPCs 
differentiation into mature oligodendrocytes, the Akt/mTOR pathway, 
which can be activated by growth factors, is known to promote 
differentiation and myelination (Tyler et al., 2009). Indeed, the 
mammalian target of rapamycin (mTOR), the major downstream player 
of this pathway, has been implicated in oligodendrocyte differentiation, 
myelin protein expression, and myelination (Guardiola-Diazet al., 2012) 
and is an upstream regulator of GPR17 (Tyler et al., 2011; Fumagalli et 
al., 2015). To elucidate the role of this pathway in the exacerbated EAE 
outcome in PNS mice, western blot analyses were performed in the 
spinal cord using antibodies against total and phosphorylated forms of 
mTOR and Akt. 
As shown in figure 4, we observed a significant decrease of Ser2448-
phosphorylated-mTOR only in EAE mice exposed to PNS (-58% vs. NO 
PNS/CTRL, P<0.05; Fig.4A) while the total form of the kinase showed a 
broad reduction trend in all the experimental groups (Fig.4B), 
suggesting that intrauterine stress exposure had a negative impact on 
mTOR activation in EAE animals. 
Then, we analyzed the levels of the protein kinase Akt which is known 
to stimulate mTOR activity (Dibble et al., 2015). Despite a significant 
decrease due only to PNS exposure (-41% vs. NO PNS/CTRL, P<0.05), 
we did not observe any specific modulation of the Serine 473 
phosphorylated form of Akt in EAE animals (Fig.4C). On the contrary, in 
line with our previous observations, we detected a significant reduction 
of the total protein only in PNS/EAE animals (-26% vs. NO PNS/CTRL, 
P<0.05; Fig.4D) confirming the implication of Akt/mTOR pathway in the 
impaired neurological score of these animals.  
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Fig.4 Analysis of BDNF/Akt/mTOR signaling 
The protein levels of the kinases phospho-mTOR at Ser2448 (A), mTOR 
total form (B), phospho-AKT at Ser473 (C) and AKT total form (D) were 
measured in the cervical spinal cord of CTRL and EAE mice prenatally or not 
exposed to stress. The data, expressed as a percentage of non-stressed 
CTRL animals (NO PNS/CTRL, set at 100%), represent the mean ± SEM of 
independent determinations. *P<0.05, **P<0.01 vs. NO PNS/CTRL; #P<0.05 
vs. PNS/CTRL (Two-way ANOVA with Fisher’s LSD). 
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4.1.2.2.3 Analysis of BDNF protein levels 
The Akt-mTOR pathway is one of the three main signaling cascades 
triggered by the binding of the neurotrophin BDNF to its high-affinity 
tropomyosin receptor kinase B (TrkB), alongside the mitogen-activated 
protein kinase (MAPK) and the phospholipase Cγ (PLCγ) pathways 
(Numukawa et al., 2010). Given the role of BDNF in the maintenance of 
neural plasticity and stress-related diseases, we assessed the protein 
levels of its mature form in the whole homogenate prepared from the 
cervical portion of the spinal cord of the mice finding a significant 
reduction of the neurotrophin in EAE animals. Indeed, as displayed in 
figure 5, encephalomyelitis decreased BDNF in non stressed EAE 
animals (-44% vs. NO PNS/CTRL, P<0.05), an effect that was even 
exacerbated in EAE mice prenatally exposed to stress (-58% vs. NO 
PNS/CTRL, P<0.01). 
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Fig.5 Analysis of BDNF protein levels 
The protein levels of the mature form of the neurotrophin BDNF were 
measured in the cervical spinal cord of CTRL and EAE mice prenatally 
exposed or not to stress. The data, expressed as a percentage of non-
stressed CTRL animals (NO PNS/CTRL, set at 100%), represent the 
mean ± SEM of independent determinations. *P<0.05, **P<0.01 vs. NO 
PNS/CTRL; #P<0.05 vs. PNS/CTRL (Two-way ANOVA with Fisher’s 
LSD). 
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has been proved that the short 3'-UTR mRNAs are restricted to the 
soma, whereas the long 3'-UTR mRNAs are also localized in dendrites 
(An et al., 2008). Accordingly, we assessed by Real Time RT-PCR the 
mRNA levels of total BDNF (transcript IX), the mRNA levels for BDNF 
long 3’-UTR as well as two major splice variants such as isoforms IV 
and VI.  
We found that the gene expression of total BDNF was significantly 
modulated in the experimental conditions with a PNS x EAE significant 
interaction (F1,25= 11.43, P<0.01). Indeed, as shown in figure 6, the 
mRNA levels of total BDNF (Fig.6A) were up-regulated in animals 
prenatally exposed to stress (+49% vs. NO PNS/CTRL, P<0.001) and 
reduced by the encephalomyelitis (-26% vs. NO PNS/CTRL, P<0.05) an 
effect even higher in PNS/EAE animals (-40% vs. NO PNS/CTRL, 
P<0.01; -60% vs. PNS/CTRL, P<0.001). A partially different profile was 
observed for the gene expression of the long 3’-UTR pool of transcripts 
(Fig.6B). Indeed, we found a significant PNS x EAE interaction (F1,22 = 
12.53, P<0.01) displayed by a strong reduction of long 3’-UTR BDNF 
only in PNS/EAE mice compared to their control littermates (-41% vs. 
NO PNS/CTRL, P<0.01), to prenatally stressed mice (-50% vs. 
PNS/CTRL, P<0.001) and to EAE animals not exposed to stress (-46% 
vs. NO PNS/EAE, P<0.01). The expression profile of isoform IV was 
similar to that observed for the total form of the neurotrophin, as 
indicated in figure 6C by the increase in PNS mice (+35% vs. NO 
PNS/CTRL, P<0.01) paralleled to a decrease after EAE in both CTRL (-
30% vs. NO PNS/CTRL, P<0.05; -48% vs. PNS/CTRL, P<0.001) and 
prenatally stressed mice (-22% vs. NO PNS/CTRL, P=0.07; -42% vs. 
PNS/CTRL, P<0.001). Conversely, the modulation of isoform VI was 
similar to what observed for the long 3’ UTR BDNF, with a specific 
decrease only in the EAE mice prenatally exposed to stress (Fig.6D, -
31% vs. NO PNS/CTRL, P<0.05; -32% vs. PNS/CTRL, P<0.05).  
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Fig.6 Analysis of BDNF gene expression 
The mRNA levels of BDNF total form (A), 3’-UTR long form (B), isoform 
IV (C) and isoform VI (D) were measured in the cervical portion of the 
spinal cord of CTRL and EAE mice prenatally exposed to stress or not. 
The data, expressed as a percentage of non-stressed CTRL animals 
(NO PNS/CTRL, set at 100%), represent the mean ± SEM of 
independent determinations. 
*P<0.05, **P<0.01, ***P<0.001 vs. NO PNS/CTRL; #P<0.05, ###P<0.001 
vs. PNS/CTRL; @@P<0.01 vs. NO PNS/EAE (Two-way ANOVA with 
Fisher’s LSD). 
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4.1.3. Discussion 
 
It is well known that adverse events in utero can markedly affect 
neurodevelopment and induce profound long-lasting alterations in the 
offspring, influencing maturational trajectories and leading to long-
lasting alterations eventually resulting in enhanced susceptibility to 
several diseases later in life (Coe and Lubach, 2005). Indeed, this “fetal 
programming” hypothesis, by which an insult occurring in a critical 
period of development has lasting effects (Barker, 1998), has been 
found to be relevant for metabolic disorders such as obesity and 
metabolic syndrome (Lauet al., 2011), cardiovascular diseases 
(Alexander et al., 2015), neuropsychiatric and neurodegenerative 
disorders (Faaet al., 2016; Modgil et al., 2014). Among this plethora of 
diseases characterized by susceptibility to fetal programming, little is 
known about the impact of insults happening to the intrauterine life on 
multiple sclerosis (MS). While several preclinical studies have been 
carried out on the effects of environmental risk factors on MS during 
adulthood (Krementsov and Teuscher, 2013), less is known on the 
influence of developmental stress exposure and only few studies have 
addressed this issue by evaluating the impact of earlier post-natal 
events -such as neonatal handling and cross-fostering- in the 
experimental autoimmune encephalomyelitis (EAE) model of MS in rats 
(Leban et al., 1995, Dimitrijević et al., 1994) or in mice (Columba 
Cabezas et al., 2009; Case et al., 2010). To our knowledge, the only 
scientific evidence on insults occurring specifically during pregnancy 
concerns the consequences of maternal infection on EAE course in the 
offspring (Solati et al., 2012; Majidi-Zolbadin et al., 2015). Instead, the 
behavioral and molecular effects of gestational exposure to stress on 
EAE course have not been investigated so far, and our work indeed 
represents the first study aiming to address this aspect.  
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Here we demonstrated that maternal stress during the last days of 
gestation worsens EAE outcome in the adult female offspring. 
Specifically, despite no differences in the weight or in nest building 
abilities were found between control and stressed mothers, we proved 
that gestational stress exerts long-lasting effects on the offspring by 
increasing susceptibility to EAE as indicated by the more severe 
symptoms scoring of prenatally stressed animals, which was statistically 
significant in both the acute and recovery phases of EAE course. Even 
though to our knowledge this is the first evidence concerning stress in 
utero, our behavioral results are in line with other studies reporting 
stress-related exacerbation of the disease at both behavioral and 
molecular levels. It has been demonstrated that chronic restraint stress 
during adulthood enhances demyelination in another MS animal model, 
the Theiler’s murine encephalomyelitis virus (TMEV) infection (Young et 
al., 2010) and that chronic sound stress resulted in increased severity of 
neurological signs and histological lesions of the spinal cord in stressed 
EAE rats compared to the non-stressed ones (Núñez-Iglesias et al., 
2010). Moreover, acute immobilization stress in adult animals shortens 
the time to EAE onset (Chandler et al., 2002).  
Previous studies have shown that the EAE acute phase is characterized 
by an increased number of GPR17-expressing cells blocked at 
immature stages and not contributing to remyelination (Chen et al., 
2009; Coppolino et al. 2018). Our data suggest that PNS exacerbates 
this defect, and that the stress-induced EAE severity may be due, at 
least in part, to reshaping of the remyelination process in the spinal 
cord, where more GPR17-positive immature oligodendrocytes were 
found. This effect has an important translational relevance since 
GPR17, a G protein-coupled receptor which is physiologically down-
regulated after the immature oligodendrocyte stage, has been identified 
as an ideal target for new regenerative therapeutic approaches for MS 
and other myelin-associated disorders (Fancy et al., 2010; Fumagalli et 
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al., 2017; Lu et al., 2018). To further investigate the potential 
mechanisms underlying its modulation by prenatal stress, we focused 
our analyses on the Akt/mTOR signaling, since mTOR has a pivotal role 
in cell growth, differentiation and survival, and has been implicated in 
oligodendrocyte development and myelination as well as in GPR17 
regulation (Tyler et al., 2009; Fumagalli et al., 2015). Moreover, 
preclinical studies indicate that, at cerebral level, this pathway is 
influenced by different stress paradigms (Chandran et al., 2012; Xia et 
al., 2016). In line with our assumptions, we observed a decrease of 
phosphorylated levels of mTOR as well as of the total form of Akt, the 
protein kinase known to stimulate mTOR activation. It is worth 
mentioning that the modulation of GPR17 by mTOR observed here is 
supported by results from a proteomic analysis revealing an increase of 
GPR17 in OPCs cultures treated with the mTOR inhibitor rapamycin 
(Tyler et al., 2011), an effect likely due to reduction of the G protein-
coupled receptor kinase (GRK2) that could, in turn, prevent 
physiological GPR17 down-regulation via the key regulator of cell 
proliferation and apoptosis Murine Double Minute 2 (MDM2) (Fumagalli 
et al., 2015). Interestingly, the Akt/mTOR pathway is known to be 
activated by several growth factors, including the neurotrophin Brain-
derived neurotrophic factor (BDNF) (Yoshii et al., 2011). The link 
between stress and BDNF is well-established (Molteni et al., 2016; Gray 
et al., 2013, McEwen et al., 2015, Calabrese et al., 2014), and different 
studies show that prenatal stress exposure can lead to BDNF 
alterations later in adulthood, both in the brain (Boersma et al., 
2014;Yeh et al., 2012; Blaze et al., 2017; Luoni et al., 2014, 2015) and 
in the spinal cord (Winston et al., 2017). Furthermore, BDNF has a 
crucial role in cell growth and survival (Murray and Holmes, 2011) and 
several studies support the hypothesis of a neuroprotective function of 
this neurotrophin in myelination and myelin repair (Acosta et al., 2013; 
De Santi et al., 2009; Linker et al., 2010). Consistently, BDNF treatment 
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using transformed bone marrow stem cells reduces inflammation and 
apoptosis in EAE mice (Makar et al., 2008) and delays symptoms onset, 
reducing the overall EAE clinical severity (Makar et al., 2009). 
It is important to note that, in our study, modulation of the Akt/mTOR 
pathway and the consequent increase in the number of GPR17-positive 
OPCs found in prenatally stressed EAE mice are paralleled by a 
reduction of BDNF. Specifically, the neurotrophin protein levels were 
reduced in the spinal cord of all mice subjected to EAE induction 
similarly to what observed for total BDNF mRNA levels, while the gene 
expression of the long 3’ UTR BDNF form was down-regulated only in 
prenatally stressed mice. This form of BDNF represents the pool of 
transcripts localized at dendritic level thanks to the so-called “dendritic 
targeting” process (Tongiorgi et al., 2008), which occurs in an activity-
dependent manner and enables the local synthesis of proteins required 
for neuronal development and plasticity, two features known to be 
altered by stress exposure (Wang et al., 2017). In line with this profile, 
we observed a similar modulation for BDNF isoform VI that belongs to 
this pool of transcripts and is localized in the distal dendrite (Baj et al., 
2011). On the contrary isoform IV, spatially segregated in the 
soma/proximal portion of the dendrite, was broadly decreased in all 
EAE mice, suggesting that PNS may alter the proper dendritic targeting 
of BDNF transcripts, thus leading to a cascade of molecular events 
culminating in impaired maturation of OPCs and in more severe EAE 
symptomatology. 
 
In conclusion, our study demonstrates for the first time that stress 
events occurring during the intrauterine life may exacerbate EAE clinical 
manifestations, giving new insights in the role of early life adversities in 
the etiopathogenesis of EAE/MS. Our data also indicate that PNS 
reshapes the process of remyelination in the spinal cord through an 
impairment of the AKT/mTOR pathway associated with a reduction of 
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BDNF levels. Since several already marketed drugs are able to 
modulate BDNF levels, the possibility of drug repositioning for multiple 
sclerosis should be addressed in future studies. 
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4.2 Long-term effect of prenatal stress exposure on acute 
responsiveness in adult mice: focus on inflammation and oxidative 
stress 
 
Maria Serena Paladini, Vittoria Spero, Andrea Carlo Rossetti and 
Raffaella Molteni  
Manuscript in preparation 
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4.2.1 Introduction 
 
During fetal life the body goes through a “critical” phase of development. 
Indeed, it is known adverse events during the prenatal period can result 
in long-lasting changes in adulthood (Darnaudéry and Maccari, 2008; 
Weinstock, 2005). These changes pertain to a wide spectrum of 
physiologic alteration: from epigenetic to inflammatory changes to 
dysregulation of the hypothalamic pituitary axis (HPA) axis. As a 
consequence, exposure to early life stressful events has been 
associated with behavioral alterations in adolescence and adulthood, 
such as aggression (Winiarsky et al., 2018), anxiety (Fonzo et al., 
2016), hyperactivity and attention-deficit disorders (Bock et al., 2017), 
cognitive impairment (Pechtel and Pizzagalli, 2011) and increased 
incidence and susceptibility of major depressive disorders as well as of 
other psychiatric illnesses (Cattaneo and Riva, 2016). Moreover, 
experiencing stress during early stages of life may also increase the 
reactivity to subsequent stressors by leaving ‘scars’ of susceptibility that 
may facilitate improper and maladaptive response to further challenges. 
Indeed, prenatal stress has been demonstrated to exert a programming 
effect on sensitive neuronal brain networks related to the stress 
response, thus leading to enduring hyper- or hypo-activation of the 
stress system. 
Therefore, aim of this study was to investigate the long-lasting 
consequences of stress in utero on the responsiveness to an acute 
challenge in adulthood, taking into account the immediate and the 
delayed molecular response. To do so, we exposed to an acute session 
of forced swim stress (6’) adult male mice born from dams that received 
daily sessions of restrain stress from gestational day 16 (GD16) until 
delivery. Our molecular analyses targeted the group of primary 
response genes (Immediate early genes) as well as mediators of the 
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inflammatory response and oxidative state and were performed in the 
mouse hippocampus 5 min or 2 h after the end of the stress. 
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4.2.2 Results 
 
4.2.2.1 Behavioral Results 
 
At first, we examined the effect of the prenatal stress on the body-
weight gain of male pups, from post-natal day 24 (PND 24) to post-natal 
day 78 (PND 78). 
 
4.2.2.1.1 Effect of prenatal stress exposure on the male progeny 
 
Since a reduction of body-weight is a common effect of stress exposure, 
we monitored the body-weight of the pups between the weaning at post-
natal day 24 (PND 24) and post-natal day 78 (PND 78). As shown in 
figure 7, pups exposed to the prenatal stress (PNS) showed a 
significantly lower body-weight with respect to control animals 
(F1,57=8,742; P=0.0045 vs. CTRL). This effect was evident until PND 56 
whereas at PND 78 the body-weight of the mice belonging the two 
experimental groups was similar. 
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Fig.7 Effect of prenatal stress exposure on the pups 
The body-weight of the animals has been monitored from PND 24 to 
PND 78. The data represents the mean ± SEM of independent 
determinations. *P<0.05, **P<0.01 vs. CTRL (Two-way ANOVA with 
Fisher’s LSD). 
 
 
4.2.2.2 Molecular Results 
 
We then investigated if prenatal stress altered systems known to be 
altered in stress-related disorders. We conducted these analyses in the 
hippocampus, one of the brain region strongly involved in psychiatric 
disorders as well as stress response. 
 
4.2.2.2.1  Effect of prenatal stress and acute stress on the expression 
of immediate early genes 
 
As a first step, we evaluated the impact of our “double hit” experimental 
paradigm on the mRNA levels of the immediate early genes (IEGs) 
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markers of neuronal activation. Indeed, it is well established that the 
IEGs expression is transiently increased in response to neuronal activit 
triggered by several stimuli. Accordingly, we found that acute stress 
(AS) in adulthood significantly affected Arc expression (F2,24=62.16; 
P<0.0001). Specifically, as shown in figure 8A, Arc mRNA levels were 
strongly up-regulated in the hippocampus of control animals after acute 
stress, an effect that was observed only at the earlier time point (t1) 
(+308%, P<0.0001 vs. CTRL/NO AS) whereas it returned to basal 
levels 2 hours later (t2). Interestingly, although prenatal stress (PNS) 
per se did not induce any change on Arc, it was able to influence the 
acute responsiveness of prenatally stressed mice, as indicated by a 
significant PNS x AS interaction (F2,24=14.05; P<0.0001). Indeed, the 
increase of Arc expression previously observed in control animals right 
after the end of the AS was not detected in animals that were exposed 
to PNS. 
Conversely, as shown in figure 8B, PNS did not affect the acute 
responsiveness in term of cFOS expression. Indeed AS significantly 
increased the mRNA levels of cFOS (F2,25=37.98; P<0.0001) at the 
acute time point (t1) not only in control mice (+189%, P<0.0001 vs. 
CTRL/NO AS) but also in prenatally stressed mice (+121%, P<0.0001 
vs. PNS/NO AS).  
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Fig.8 Modulation of IEGs gene expression by prenatal stress and acute 
stress 
The mRNA levels of Arc (A) and cFOS (B) were measured in the 
hippocampus of control (CTRL) and prenatally stressed (PNS) mice 
exposed in adulthood to an acute stress (AS). The analyses were 
performed 5 minutes (t1) or 2 hours (t2) after the end of the stress in 
comparison with control unstressed animals (CTRL/NO AS). The data, 
expressed as percentage of CTRL/NO AS animals (set at 100%), are 
the mean ± SEM of independent determinations. ***P<0.0001 vs. 
CTRL/NO AS; ###P<0.0001 vs. PNS/NO AS; &&&P<0.0001 vs. AS (Two-
way ANOVA with Fisher’s LSD). 
 
 
4.2.2.2.2  Effect of prenatal stress and acute stress on the expression 
of inflammatory cytokines 
 
Since stress-related disorders are known to be associated with 
alterations of the inflammatory system and stressful events affects the 
levels of specific mediators of the inflammatory response, we analyzed 
the expression of pro- and anti-inflammatory cytokines in our 
experimental paradigm. The release of cytokines may represent the first 
response of the immune system to cope an acute stress. Accordingly, 
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we analyzed the mRNA expression of IL-1β, IL-6 and TGF-β, and the 
protein levels of IL-10.  
As shown in figure 9A, despite the large variability, we found a 
significant effect of PNS on IL-1β gene expression (F1,25=4.79; P<0.05). 
Specifically, the mRNA levels of the cytokine were increased in the 
hippocampus of prenatally stressed mice (+95%, P<0.05 vs. CTRL/NO 
STRESS). Conversely, we did not observe any changes of IL-1β after 
acute stress, although the up-regulation of the cytokine detected in 
prenatally stressed animals was significantly lower 2 hour after the 
exposure to the acute stress (-48%; P<0.05 vs. PNS/NO AS), as 
indicated by the statistical analysis (F2,25=4.871; P<0.05). 
Next, we evaluated the impact of our paradigm on the mRNA levels of 
IL-6 (Fig.9B) finding a similar profile in both control and prenatally 
stressed mice. Specifically, the expression of this cytokine was not 
affected by the prenatal stress but it was altered in response to the 
acute stress (F2,30=5.357; P<0.05). In particular, IL-6 was up-regulated 
right after the end of the AS (t5’) in both control (+45% vs. CTRL/NO 
AS, P<0.05) and prenatally stressed animals (+47% vs. PNS/NO AS, 
P<0.05). This effect persisted 2 hours after the end of the stress, 
although it was significant only in PNS mice (+41% vs. PNS/NO 
STRESS, P<0.05).  
We then decided to investigate the modulation of the anti-inflammatory 
cytokines TGF-β andIL-10 (Fig.9C, D). The Two-way ANOVA analysis 
of TGF-β gene expression revealed a significant effect of PNS 
(F1,25=13.52; P<0.01). Indeed, PNS animals exposed to the second 
challenge, displayed lower levels of the cytokine at both time points 
compared to control mice (-67% vs. CTRL/AS 5’, P<0.01; -37% vs. 
CTRL/AS 2h, P<0.01 respectively). Regarding IL-10, we found a trend 
to increase in control mice in response to the AS that reached a peak 2 
hours after the end of the stress (+30% vs. CTRL/NO AS). This 
modulation was not observed in PNS animals, which displayed reduced 
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levels of IL-10 in basal condition (-32% vs. CTRL/NO AS), an effect that 
did not reach the statistical significance despite a main effect from PNS 
(F 1,18=19.27; P<0.001).  
 
 
 
 
Fig.9 Modulation of pro- and anti-inflammatory cytokines by prenatal 
stress and acute stress. 
The mRNA levels of the pro-inflammatory cytokines IL-1β (A), IL-6 (B) 
and TGF-β (C) and the protein levels of anti-inflammatory cytokine IL-10 
(D) were measured in the hippocampus of control (CTRL) and 
prenatally stressed (PNS) mice exposed in adulthood to an acute stress 
(AS). The analyses were performed 5 minutes (t1) or 2 hours (t2) after 
the end of the stress in comparison with control unstressed animals 
(CTRL/NO AS). The data, expressed as percentage of CTRL/NO AS 
animals (set at 100%), are the mean ± SEM of independent 
determinations. *P<0.05 vs. CTRL/NO AS; #P<0.05 vs. PNS/NO AS; 
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°°P<0.01 vs. CTRL/AS t1; @P<0.05, @@P<0.01 vs. CTRL/AS t2 (Two-
way ANOVA with Fisher’s LSD). 
 
 
4.2.2.2.3 Effect of prenatal stress and acute stress on mediators of 
the oxidative balance 
 
Lastly, we analysed the potential impact of prenatal stress and its 
influence on the effect of the acute challenge focusing on mediators of 
the redox balance. The modulation of the redox balance plays a key 
role in response to several acute and chronic stimuli. In stress 
conditions, specific anti-oxidant mechanisms are activated in order to 
rapidly restore the right balance in the cell and prevent the damage 
caused by the high cytotoxicity of pro-oxidant molecules. Accordingly, 
we investigated the expression of both pro- and anti-oxidant mediators 
and enzymes and in particular, we analysed the expression of the anti-
oxidant mediators Nrf2, Srxn1 and Prx-SO3 and that of the pro-oxidant 
enzyme Nox2. 
We first measured the protein levels of Nrf2 in the nuclear component, 
where it acts as transcription factor for several anti-oxidant enzymes. 
We found that its levels were not significantly affected by PNS under 
basal conditions, however the prenatal paradigm influenced the 
response to the acute challenge, as indicated by a significant PNS x AS 
interaction (F2,24=4,361; P<0.05). Specifically, as shown in figure 10A, 
Nrf2 was up-regulated by AS in both control and PNS mice at the earlier 
time point, an effect that reached the statistical significance only in PNS 
mice (+65%, P<0.05 vs. PNS/NO AS). In this experimental group, this 
increase was even higher 2 hours after the end of the challenge 
(+105%, P<0.01 vs. PNS/NO AS), whereas it did not persist in control 
mice. 
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Next, we assessed the mRNA levels of sulfiredoxin1 (Srxn1), one of the 
enzymes whose transcription is regulated by Nrf2. The analyses 
revealed that Srxn1 was modulated by both PNS (F1,25=7.739; P<0.05) 
and AS (F2,25=4.011; P<0.05). In particular, as shown in fig. 10B, we 
observed a trend to decrease of its gene expression after PNS in basal 
conditions (-30% vs. CTRL/NO AS) whereas the enzyme was up-
regulated after AS. The effect of the acute challenge was observed in 
both control and prenatally stressed mice, however only in the latter 
experimental group it reached the statistical significance; probably due 
to the lower levels observed in PNS mice not exposed to AS.  
We then examined the level of the over oxidized enzyme Prx-SO3 
(Fig.10C) finding no changes by the prenatal stress paradigm but a 
significant modulation by the acute stress (F2,18=4.473; P<0.05) and a 
PNS X AS interaction (F2,17=4.733; P<0.05). More in detail, the protein 
levels of Prx-SO3 were slightly up-regulated by the acute challenge in 
both control (+34% vs. CTRL/NO AS) and prenatally stressed mice 
(+40% vs. PNS/NO AS) 5 minutes after the end of the stress, although 
this effect was not statistically significant. This trend in increase was not 
observed at the longer time point in control mice, while it was even 
higher in PNS animals (+116% P<0.01 vs. PNS/NO AS).  
Moreover, we assessed the gene expression of the pro-oxidant enzyme 
Nox2 (Fig.10D). Nox2 mRNA levels were not statistically affected by 
PNS, even though a trend can be observed. Nox2 mRNA levels tend to 
decrease in control mice exposed to acute stress, while are higher in 
PNS animals at the longer time point (+49%; P<0.05 vs. CTRL/AS 2h).  
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Fig.10 Modulation of modulators of the redox balance by prenatal stress 
and acute stress 
The nuclear protein levels of Nrf2 (A), the mRNA levels of Srxn1 (B), the 
protein levels of PRX-SO3 in the total homogenate (C) and the mRNA 
levels of Nox2 were measured in hippocampus of control (CTRL) and 
prenatally stressed (PNS) mice exposed in adulthood to an acute stress 
(AS). The analyses were performed 5 minutes (t1) or 2 hours (t2) after 
the end of the stress in comparison with control unstressed animals 
(CTRL/NO AS). The data, expressed as percentage of CTRL/NO AS 
animals (set at 100%), are the mean ± SEM of independent 
determinations. #P<0.05, ##P<0.01 vs. PNS/NO AS; @P<0.05, 
@@P<0.01,@@@P<0.001 vs. CTRL/AS t2 (Two-way ANOVA with 
Fisher’s LSD). 
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4.2.3 Discussion  
 
The present study demonstrates that the exposure to a prenatal stress 
paradigm not only has long-term effects on the inflammatory and 
oxidative balance in the hippocampus of adult mice under basal 
conditions, but it is also able to interfere with their responsiveness to a 
challenging situation such as an acute stress. Based on the etiological 
role of early-life stressful experiences for psychiatric disorders, our 
results support the idea that this may occur through the impairment of 
specific molecular systems crucial for a proper coping with challenging 
situations. 
It is well established that stress represents the main environmental risk 
factor for the development of several psychiatric disorders such as 
major depression disorder, schizophrenia and bipolar disorder. 
Particularly, given the importance of perinatal periods for brain 
development, stressful events occurring during CNS development may 
induce long-term brain structural and functional alterations, that could 
enhance the vulnerability to mental disorders later in life (Kim et al., 
2015; Markham and Koenig, 2011). These brain abnormalities reflect 
the impairment of neuroplasticity mechanisms that characterize 
psychiatric disorders and that may be defined as the brain’s capacity to 
alter its structure and function in reaction to environmental stimuli.  
For this project we decided to use a “double hit model” to investigate the 
long-term impact of prenatal stress in mice on molecular mediators of 
the cerebral inflammatory and oxidative state known to be altered in 
psychiatric disorders. Specifically, we analysed the effects produced by 
prenatal stress in adulthood in both basal conditions and after the 
exposure to an acute challenge in male mice. To this aim, we exposed 
pregnant mice to daily sessions of restraint stress during the last 
gestational week, and the male progeny to an acute forced swim stress 
in adulthood.  
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At first, we found that stress reduced the body-weight gain of the male 
pups after the weaning until adulthood. This result is in line with 
preclinical (Lesage et al., 2004) and clinical studies where in addition 
stress-induced low birth weight was associated with long-term reduction 
of the cortical surface area and impaired cognition (Wainstock et al., 
2014; Walhovd et al., 2016). These data demonstrated that our prenatal 
stress paradigm had an impact on the progeny, suggesting possible 
alterations also at molecular level. Moreover, since stress affects 
neuroplasticity, which is a “dynamic” concept, we decided to evaluate 
potential long-term molecular changes not only in basal conditions but 
also in response to an acute challenge. 
As a first step, we decided to evaluate if prenatal stress could affect the 
induction of immediate early genes (IEGs), an index of neuronal 
activation, which occurs in response to an acute challenge. The 
synthesis of the IEGs occurs within minutes and play important roles in 
several cellular processes involved in synaptic plasticity, LTP, and LTD 
(long-term potentiation and long-term depression respectively), thus 
influencing the function of various neural circuits (Loebrich and Nedivi, 
2010). As expected, the expression of the IEG Arc and cFOS was 
increased following the acute stress at the earlier time point, however, 
this effect was not observed for Arc in the hippocampus of prenatally 
stressed mice. Arc mRNAs are known to undergo a rapid transport to 
dendrites and a local synaptic translation. The protein synthesized is 
then required for synaptic plasticity, memory consolidation, LTP and 
LTD, processes that involve multiple neurotransmitters such as 
glutamate and dopamine and their receptors (Chowdhury et al., 2006; 
Plath et al., 2006).  
Among the molecular processes altered in psychiatric diseases and 
known to be a target of stress, we investigated the inflammatory 
response, which also represents one of the primary reactions to an 
acute challenge. Interestingly, we found increased expression of the 
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pro-inflammatory IL-1β in prenatally stressed animals, in accordance 
with other studies (Diz-Chaves et al. 2013; Ślusarczyk et al., 2015) and 
we hyphotesized that the induction of a pro-inflammatory state by 
prenatal stress could also impair the ability of the animals to respond to 
subsequent challenges, contributing to behavioural alterations. Since 
increased level of IL-1β has been linked to psychiatric diseases such as 
depression, schizophrenia and bipolar disorder, the prenatal stress-
induced up-regulation of this cytokine could be one possible molecular 
mechanism for the stress-related development of depressive-like and 
other pathological behaviours, as it has already been proposed in 
animal models (Kubera et al., 2011). 
In parallel, we found that prenatal stress reduced the levels of the anti-
inflammatory cytokine IL-10. Changes in IL-10 have been associated 
with depressive symptoms in humans (Song et al., 2009) and are 
proposed to influence depressive behaviour. For example, it has been 
reported that chronic restraint stress induced a long-lasting decrease of 
hippocampal IL-10 mRNA and circulating protein levels in animals 
showing depressive-like behaviour (Voorhees et al., 2013). Moreover, 
IL-10 administration before performing a forced swim test was able to 
reverse the chronic stress-induced depressive phenotype, supporting a 
role for IL-10 in affecting behaviour.  
Alterations of inflammatory response may have several consequences, 
among them, changes in the redox status, which is known to occur also 
in psychiatric disorders (Smaga et al., 2015). At first, we decided to 
evaluate the functioning of the anti-oxidant machinery, analysing one of 
the nuclear factor E2-related factor 2 (Nrf2) pathways. Nrf2 is a 
transcriptional factor known to translocate in the nucleus under 
oxidative stress conditions, and through the binding of the antioxidant 
responsive element (ARE) is able to activate the transcription of many 
different anti-oxidant factors. Among those factors there is Sulfiredoxin1 
(Srxn1), a small enzyme that catalyses the reduction of hyper-oxidized 
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peroxiredoxins (Prxs), allowing them to be reactivated to function again 
as a reducer of H2O2 in H2O using the reducing power of glutathione 
(GSH) and thioredoxin (Trx) (Soriano et al., 2008; Sunico et al., 2016). 
In our study, we observed that while in control animals the acute stress 
was able to induce a slight increase in the translocation of Nrf2 into the 
nucleus that disappeared after 2 hours, in prenatally stressed animals, 
the increase of the nuclear Nrf2 was greater and amplified two hours 
after the acute stress exposure. The increased expression of nuclear 
Nrf2 could be the reaction to an over-production of free radicals and 
reactive species in prenatally stressed animals after a stimulus, as 
indicated in studies showing increased and persistent translocation of 
Nrf2 into the nucleus in situation of oxidative stress (Cui et al., 2016). In 
line with the increased nuclear levels of Nrf2, we observed that acute 
stress up-regulated Srxn1 in both controls and prenatally stressed mice, 
although only in prenatally stressed animals this increase reached the 
statistical significance. Nevertheless, the up-regulation of Srxn1 seemed 
to be efficient only in control animals, in which, after a slight increase in 
the protein levels of Prx-SO3 right after the acute stress, the levels of 
the hyper-oxidized protein returned to basal levels. By contrary in 
prenatally stressed animals, the production of Prx-SO3 kept rising two 
hours after the end of the acute stress, suggesting once again an 
imbalance in the oxidative state of those animals, which could be due to 
a greater production of reactive species or to a malfunction in their anti-
oxidant machinery.  
We then examined a pro-oxidant factor, the NADPH oxidase 2 (NOX2), 
whose function is to generate ROIs (Reactive Oxidant Intermediates), 
able to damage DNA, proteins and lipids, and usually activated in order 
to prepare the brain for a pathogens attack. We observed a gradual 
decrease in the mRNA levels of this enzyme in the acutely stressed 
animals, effect that was not maintained in prenatally stressed groups. 
Spiers et al. found a similar result, with a down-regulation of NOX2 after 
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an acute restraint stress (Spiers et al., 2016), suggesting that this 
reduction might be due to the activation of the peroxisome proliferator-
activated receptor. 
 
In conclusion, from this study emerged that prenatal stress is able to 
modify the basal levels of specific inflammatory and oxidative 
mediators, but it is also capable to influences the response of these 
systems in reaction to an acute challenge. Moreover, our results 
highlight that the influence of the prenatal stress on the acute 
responsiveness was stronger 2 hours after the challenge. This finding 
suggests that the recovery after an acute challenge is in some way 
influenced by prenatal stress, and that the physiological reestablishment 
of homeostasis is impaired by the exposure to early-life adversities.  
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mild traumatic brain injury outcome in adolescent mice 
 
Maria Serena Paladini, Karen Krukowski, Susanna Rosi and Raffaella 
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Unpublished data 
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4.3.1 Introduction 
 
Adolescence, the period marking the transition from childhood to 
adulthood, is frequently marked by age-specific behavioral phenotypes, 
such as increased emotional reactivity, social activity, playfulness and 
risk-seeking behavior (Casey et al., 2008). This is typically coincident 
with changes in the social environment, such as spending more time 
with peers and less with parents. Together with the neurobiological 
changes characteristic of puberty, these age-specific behavioral 
features may enhance the susceptibility to environmental factor, such 
as stress. Indeed, not only the nature of stressors changes during 
adolescence, but also the mechanisms the adolescent body 
orchestrates to respond to stress. Supporting this, animal studies 
indicated that an equivalent dose of corticosterone increased gene 
expression to a greater degree in the adolescent compared to adult 
hippocampus (Lee et al., 2003). Moreover, it is well recognized that the 
brain areas known to be the most sensitive to stress in adulthood, 
namely the hippocampus, prefrontal cortex, and amygdala, are still 
under development during adolescence (Giedd and Rapoport, 2010). 
Thus, the convergence of all these factors may render the adolescent 
brain especially sensitive to external adverse perturbations, and 
therefore more vulnerable to physical and psychological morbidities 
(Romeo and McEwen, 2006). 
With these premises, in this project I deepened how experiencing stress 
during adolescence may have repercussions on a further external insult 
extremely frequent during this time of life, such as brain concussion. 
Indeed, because of their usual involvement in sports and higher-risk 
activities, adolescent sustain the majority of sports-related brain injuries 
(Semple et al., 2015). Traumatic brain injury (TBI), defined as an insult 
to the brain from an external mechanical force, is known to produce 
both acute and chronic consequences that lead to permanent 
disabilities. Indeed, the direct consequences of a single or repetitive 
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concussions can result in various secondary pathological conditions, 
including seizures, sleep disorders, neurodegenerative diseases, 
neuroendocrine dysregulation, and psychiatric problems (Bramlet and 
Dietrich, 2015). Despite stress-related disorders as a consequences of 
TBI have been largely investigated (Bryant, 2011), the long-term 
repercussions of early-life adversities –specifically during adolescence- 
on behavioral and molecular outcomes after TBI have not been 
examined yet. 
For this reason, on postnatal days (PND) 28, I exposed adolescent 
C57Bl6 male mice to 10 days of repeated social defeat stress. The 
social defeat paradigm possesses higher face, predictive, and 
ethological validity that results in enduring behavioral and 
neurobiological changes that mimic several symptoms of the human 
condition such as decreased preference for sucrose and increased 
social avoidance, behaviors collectively described as a depressive-like 
phenotype (Krishnan and Nestler, 2008; Berton et al., 2006). Four days 
after the end of the stress, at PND 42, the mice received 2 mild 
concussions, 24h apart from each other, using the Closed-Head Impact 
Model of Engineered Rotational Acceleration (CHIMERA) apparatus. 
The mice were then assessed for anxiety-like behavior in the elevated 
plus maze and learning and memory in the novel object recognition 
(NOR) test.  
I carried out this experiment during the 6 months I spent as a visiting 
PhD student at the laboratory of Brain Injury, Neuroinflammation and 
Cognitive Function headed by Professor Susanna Rosi at the University 
of California, San Francisco. 
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4.3.2 Results 
 
4.3.2.1 Impact of previous stress exposure on 2rTBI behavioral 
outcome 
 
Starting from one week after injury (dpi 7) at PND 49 mice were tested 
in the elevated plus maze (EPM) and at PND 64 (dpi 21) for the novel 
object recognition test.  
 
To examine if 2rTBI mice were influenced by previous stress exposure 
in developing anxiety-like and security seeking behavior, we evaluated 
these phenotypes using the elevated plus maze in which mice freely 
explore either two closed, dark arms or two open, illuminated arms. The 
Two-way ANOVA analysis showed a significant effect of stress 
exposure (F1,42=8.447; P<0.01). Indeed, defeated mice spent a 
significantly shorter time in the open compared to the sham not stressed 
animals, although this effect is statistically significant only in stressed 
sham animals (-33% vs. No Stress/sham, P<0.01) (Fig. 11A). 
We then test the mice for hippocampal-dependent memory impairment 
using the NOR test. As depicted in figure 11B, we observed a significant 
Stress x 2rTBI interaction (F1,48=10.26; P<0.01). More in detail, RSDS 
mice displayed no preference toward either object, resulting in a lower 
discrimination index compared to not stressed sham group (P<0.05 vs. 
No Stress/sham). 2rTBI mice as well showed a tendency, although not 
significant, in a lower discrimination index. Interestingly, mice that were 
exposed to the combined paradigm, exhibited an increased preference 
toward the novel object, with a higher discrimination index both 
compared to the stressed sham counterpart (P<0.001 vs. RSDS/sham) 
and to only injured animals (P<0.05 vs. No Stress/2rTBI). 
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Fig.11 Impact of previous stress exposure on 2rTBI behavioral outcome 
Mice were tested in the EPM at PND 49 and the time in the open areas 
of the maze was analyzed (A). At PND 64, the hippocampal-dependent 
recognition memory were tested using the NOR paradigm and the 
discrimination index (B) was calculated as described above. For all the 
analyses the data are expressed as mean of the examined variable ± 
SEM of independent determinations. *P<0.05, **P<0.01 vs. 
NoStress/sham; #P<0.05 vs. No Stress/2rTBI; °°°P<0.001 vs. 
RSDS/sham (Two-way ANOVA with Fisher’s LSD). 
 
 
4.3.2.2 Analyses of Iba1 immunostaining in the hippocampus of 
mice exposed to social defeat stress and 2rTBI during adolescence 
 
Microglia cells are the macrophagic resident cells of the brain, 
responsible of the first line defense against immune alterations within 
the brain. In the so-called “resting state” microglia surveil the 
microenvironment searching for pathogens or signs of disuse damage. 
At this stage microglia have a dendritic morphology characterized by 
long and ramified processes. In the “activated state” microglia have an 
amoeboid form with high mobility toward the site of damage. Microglia 
activation has been detected after exposure to social defeat stress in 
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different brain areas (Stein et al., 2017) as well as in animals that 
received different models of TBI (Donat et al., 2017).  
To investigate microgliosis in the hippocampus, we quantified the 
density of Iba-1-positive cells in the CA1 region. As depicted in figure 12 
we didn’t observe any difference in the % of Iba1 staining between the 
different experimental groups.  
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Fig.12 Analyses of Iba1 immunostaining in the CA1 
% of Iba1 staining was measured in the CA1 region of the hippocampus 
of mice exposed to social defeat stress and 2rTBI during adolescence. 
Representative images of Iba1 staining showing Iba1 staining in red and 
DAPI in blue. Scale bar = 50 µm 
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4.3.3 Discussion 
 
All aspects of life require stress. However, the type of stressors we face 
and how we respond to them change throughout our life. Adolescence 
represents a period of life when both the type of stressors and the 
adaptation mechanisms orchestrated by the body are changing. Indeed, 
compared to other life phases, the stressors that adolescents have to 
face are mainly of a social character. Social stress can take place either 
in the home environment or during the increasing amount of time that 
adolescents spend with peers, when bullying behaviors are extremely 
frequent (Buwalda et al., 2011). In this respect, negative social 
experiences during adolescence are known to increase the risk of 
psychiatric disorders in adulthood (McCormick, Green 2013). Another 
peculiar feature of adolescence is the increased risk of experiencing 
injuries, due to the fact that adolescents are more likely than adults to 
participate in organized sport but also to engage in risky and impulsive 
behaviors.  
In this study I investigated if a previous exposure to a social stress 
could alter the behavioral and molecular outcome after experiencing 
concussions, a brain injury extremely frequent during adolescence 
(Semple et al., 2015). I took advantage of the repeated social defeat 
stress paradigm, a well-recognized model of psychological and social 
stress that is able to induce depressive-like phenotypes at preclinical 
level (Golden et al., 2011) and of a recently developed model of TBI, the 
Closed-Head Impact Model of Engineered Rotational Acceleration 
(CHIMERA) that has been only partially characterized. I firstly 
investigated how this combined experimental model could affect two 
behavioral features that are known to be altered by stress and TBI, such 
as anxiety-like/security seeking behavior and memory. Using the 
elevated plus maze I assessed and deepened the stress-induced 
anxiety-like phenotype and the injury-induced risk-taking behavior. 
Indeed, while stress exposure is known to reduce the time spent in the 
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open areas of the maze (Hata et al., 2001), repetitive mild concussions 
(n=5) using the CHIMERA apparatus have been demonstrated to have 
an opposite effect, suggesting post-injury behavioral disinhibition and 
increased risk-taking phenotype (Nolan et al., 2018). In my experimental 
settings, socially defeated mice displayed an anxiety-like phenotype, 
spending less time in the opens regardless of the concussions. On the 
other hand, TBI mice that received two mild concussions didn’t display 
the risk-taking behavior. Since this specific injury model is very recent, 
there are no evidences about the effect of two mild concussions on the 
EPM task, either in adult or in adolescent animals, and therefore this is 
the first time, to the best of our knowledge, that this aspect is evaluated. 
However, dissecting if the observed effect was due to the age of the 
mice or the number of injuries needs still to be elucidated. I next 
investigated if stress and/or TBI could trigger hippocampal-related 
memory deficits using the NOR test. I observed a reduction of the 
discrimination index (a parameter that indicates the preference for the 
novel object) in mice that were exposed to RSDS and in non stressed 
animals that received the two mild concussions. This result is in line 
with other studies that demonstrated stress-induced (Patki et al., 2013) 
and trauma-induced (Bodnar et al., 2019) memory impairment. 
However, in this experiment, stressed mice that received the 
concussions didn’t show any impairment. A possible explanation to this 
interaction could be that the combined condition rendered this group of 
mice overactive. Therefore, the observed data could result from a 
generally increased exploring time.  
The employed version of the NOR consisted in 24 hours between the 
exposure to two identical objects and the novel one, thus testing 
hippocampal memory. Therefore, the molecular analyses were focused 
on this brain area, sensitive to stress exposure (Kim et al., 2015).  
The analysis of the % of Iba1+ area carried in the mice CA1 didn’t show 
any significant difference between the different experimental conditions, 
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suggesting that the observed behavioral results are not attributable to 
differences in microglia activation. 
 
The obtained results represent the first evidences of a possible 
environmental role of previous social stress on TBI outcome during 
adolescence. Nevertheless, further investigations are needed to better 
characterize this new experimental model.  
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4.4.1 Introduction 
 
The role of stress in the etiology of mood disorders has been widely 
investigated. Major depressive disorder (MDD) is the commonest cause 
of disability and affects nearly 16% of the global population (Kessler et 
al., 2003), however despite the large interest in improving the available 
therapeutic approaches, the pharmacological treatment still presents 
some critical issues, such as the high rate of resistance (Al-Harbi, 
2012), the long latency of the therapeutic effect (Machado-Vieira et al., 
2010) and the highly frequent occurrence of relapses, with at least 50% 
of those who recover from a first episode of depression having one or 
more additional episodes in their lifetime (Burcusa and Iacono, 2007). 
Indeed, while it is expected that antidepressant or other psychotropic 
drugs used in the treatment of depression may prevent relapse, little is 
known on how long-term pharmacological treatments properly work to 
manage the chronic course of the pathology and to maintain their 
clinical efficacy. Exposure to stressful events during adult life may leave 
long-term signature and increase the response to subsequent stressors. 
Indeed, it is possible that not all the systems impaired by stress are 
restored during the remission of the symptoms, thus leaving ‘scars’ of 
vulnerability that may facilitate the relapse to the pathology. Therefore, 
the main purpose of this part of my project was to investigate if and how 
stress-induced changes during adulthood may persist after a recovery 
period and to understand the molecular mechanisms that may underlie 
the precipitation of a recurrent episode. Moreover, we aim to establish 
whether such changes can be modulated by the treatment with the 
antipsychotic lurasidone, to gain insights its potential ability to prevent 
or reduce the individual susceptibility to subsequent negative events.  
To address these objectives, adult male rats were exposed to four 
weeks of chronic restraint stress and, starting from the second week, 
received either vehicle or lurasidone chronically. The animals were then 
left undisturbed for the subsequent three weeks. Furthermore, after this 
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window of recovery, the rats were subjected to an acute immobilization 
stress. We focused our analyses on regulators of the oxidative balance, 
increasingly recognized to have a crucial role in the etiology of 
psychiatric disorders (Fraunberger et al., 2016), in the hippocampus, a 
brain region primary involved in the stress response and in the 
integration of information for past with present stimuli (Borders et al., 
2017). 
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4.4.2 Results 
 
4.4.2.1  Effect of acute stress exposure on the gene expression of 
the oxidative regulators Nox2 and Nrf2 after 3 weeks of washout from 
CRS and lurasidone treatment 
 
Our laboratory has previously demonstrated that lurasidone is able to 
counteract the behavioral depressive-like phenotype induced by chronic 
stress by acting on key players in the maintenance of the oxidative 
balance in the brain, such as NADPH oxidase 2 (Nox2), an enzyme 
responsible for the production of reactive oxygen species (ROS), and 
the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a transcription 
factor involved in the control of the cellular anti-oxidant response 
(Rossetti et al., 2018). In my PhD project I investigated if the modulation 
of these genes by chronic stress and lurasidone treatment could still be 
observed after a washout period. Moreover, we examined the possibility 
that previous chronic restraint stress (CRS) exposure and/or chronic 
lurasidone treatment may sensitize these systems to further 
environmental challenges, such as an acute stress. 
As depicted in figure 13A and B, despite some tendencies, we did not 
observe any significant change in the mRNA levels of Nox2 attributable 
to CRS and lurasidone three weeks after the end of the stress in the 
dorsal and ventral portion of the hippocampus. Regarding the effect of 
acute stress, while we couldn’t find any significant alteration in the 
dorsal hippocampus, in the ventral hippocampus we found that Nox2 
gene expression was reduced after the acute stress only in rats treated 
with lurasidone compared to the not treated control and to the treated 
control without the acute challenge (-32% vs. No CRS/VEH/No AS, 
P<0.05; -31% vs. No CRS/LUR/No AS, P<0.05) (Fig.13B). 
When we investigated the antioxidant counterpart, we did not find any 
significant modulation in both the areas analysed. However, in the 
ventral hippocampus, we observed a tendency toward a decrease of 
100 	
Nrf2 in response to acute stress in both control (-14% vs. No 
CRS/VEH/NoAS, P>0.05) and chronically stressed animals (-14% vs. 
CRS/VEH/No AS, P>0.05), not present when the animals were treated 
with lurasidone (Fig.13D). 
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Fig.13 Effect of acute stress exposure on the gene expression of Nox2 
and Nrf2 after 3 weeks of washout from CRS and lurasidone treatment 
The mRNA levels of Nox2 and Nrf2 were measured in the dorsal (A, C) 
and ventral (B, D) hippocampus of not stressed (No CRS) and stressed 
(CRS) rats treated with vehicle (VEH) or lurasidone (LUR) and exposed 
after 3 weeks of washout to acute stress (AS) or not (No AS). The data, 
expressed as percentage of No CRS/VEH/No AS animals (set at 
100%), are the mean ± SEM of independent determinations. *P<0.05 
vs. No CRS/VEH/No AS; £P<0.05 vs. No CRS/LUR/No AS (Three-way 
ANOVA with Fisher’s LSD). 
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4.4.2.2  Effect of acute stress exposure on the gene expression of 
the antioxidant enzyme Srxn1 after 3 weeks of washout from CRS and 
lurasidone treatment 
 
We next analyzed one of the detoxifying enzymes whose transcription is 
mediated by Nrf2, i.e. sufiredoxin1 (Srnx1). Regarding the dorsal 
hippocampus, the Three-way ANOVA analysis depicted a significant 
CRS x treatment x AS interaction (F1,60=6.829, P=0.0113). More in 
detail, we found that acute stress significantly increased the gene 
expression of this antioxidant enzyme in rats not exposed to CRS 
treated with vehicle (+38% vs.No Stress/VEH/NoAS, P<0.05) (Fig.14A). 
Interestingly, Srxn1 up-regulation was not found in animals exposed to 
CRS and treated with vehicle (-33% vs. No CRS/VEH/AS, P<0.01), 
which showed instead a slight decrease compared to CRS rats not 
exposed to the acute challenge (-10% vs. CRS/VEH/No AS, P>0.05). It 
is noteworthy that lurasidone, when given to CRS rats, elicited an 
almost significant restorative effect on Srxn1 modulation after acute 
stress (+30% vs. CRS/LUR/No AS, P=0.07). 
The Three-Way ANOVA analysis of Srxn1 modulation in the ventral 
hippocampus highlighted a stronger effect of acute stress (F1,69=28.57, 
P<0.0001). Indeed, the up-regulation of Srxn1 induced by acute stress 
–compared to sham animals- is statistically significant in the not treated 
group (+37% vs. No CRS/VEH/No AS, P<0.001), in the group of animal 
treated with lurasidone (+28% vs. No CRS/VEH/No AS, P<0.001) and in 
CRS rats, although in a less accentuated fashion, regardless the 
treatment (+24% vs. No CRS/VEH/No AS, P<0.05; +23% vs. No 
CRS/VEH/No AS, P<0.05 of CRS/VEH/AS and CRS/LUR/AS groups, 
respectively). However, when we compared the increase of Srxn1 of 
acutely stressed animals to the proper counterpart, the data reach 
significance in not treated sham animals (+37% vs. No CRS/VEH/No 
AS, P<0.001), in treated not stressed animals (+28% vs. No 
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CRS/LUR/No AS, P<0.01) but not in CRS rats that received the vehicle. 
It’s interesting to note that this impairment due to the previous chronic 
stress exposure was partially normalized by the pharmacological 
treatment with lurasidone. Indeed, the acute stress-induced up-
regulation of Srxn1 was restored in CRS rats treated with the 
antipsychotic (+24% vs. CRS/LUR/No AS, P<0.05) (Fig.14B). 
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Fig.14 Effect of acute stress exposure on the gene expression of Srxn1 
after 3 weeks of washout from CRS and lurasidone treatment 
The mRNA levels of Srxn1 were measured in the dorsal (A) and ventral 
(B) hippocampus of not stressed (No CRS) and stressed (CRS) rats 
treated with vehicle (VEH) or lurasidone (LUR) and exposed after 3 
weeks of washout to acute stress (AS) or not (No AS). The data, 
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expressed as percentage of No CRS/VEH/No AS animals (set at 
100%), are the mean ± SEM of independent determinations. *P<0.05, 
***P<0.001 vs. No CRS/VEH/No AS; ##P<0.01 vs. No CRS/VEH/AS; 
££P<0.01 vs. No CRS/LUR/No AS; @P<0.05 vs. CRS/LUR/No AS 
(Three-way ANOVA with Fisher’s LSD). 
 
 
4.4.2.3  Effect of acute stress exposure on the gene expression of 
Gpx1, Gpx4 and Mt-1a antioxidant enzymes after 3 weeks of washout 
from CRS and lurasidone treatment 
 
Given the strong involvement of Srxn1 in the acute antioxidant response 
to a second challenge, we next examined the gene expression of two 
further antioxidant enzymes downstream to the transcriptional activity of 
Nrf2, namely the enzymes cytosolic glutathione peroxidase 1 (Gpx1) 
and phospholipid-hydroperoxide glutathione peroxidase 4 (Gpx4) and 
the gene expression of the non-canonical heavy-metal binding 
antioxidant, metallothionein 1a (Mt-1a) (Fig.15). 
Regarding Gpx1 mRNA levels, the Three-way ANOVA analysis in the 
dorsal hippocampus revealed a significant effect of CRS (F1,59=4.440, 
P=0.0394), a significant CRS x LUR interaction (F1,59=19, P<0.0001) 
and significant CRS x LUR x AS interaction (F1,59=7.224, P=0.0093). As 
a result, we observed a significant reduction of Gpx1 in not treated CRS 
rats, not exposed (-35% vs. No CRS/VEH/No As, P<0.001) or exposed 
to acute stress (-26% vs. No CRS/VEH/No As, P<0.01). Interestingly, 
lurasidone restored Gpx1 levels in CRS animals, resulting in a 
significant increase compared to CRS/VEH/No AS animals (+52% vs. 
CRS/VEH/No AS, P<0.001) (Fig.15A). With respect to the ventral 
hippocampus, the Three-way ANOVA analysis revealed a significant 
effect of CRS (F1,70=8.183, P=0.0056) and significant CRS x LUR x AS 
interaction (F1,70=8.799, P=0.0041). More in detail, we observed a 
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significant reduction of the antioxidant’s mRNA levels in CRS animals 
exposed to the acute challenge (-28% vs. No CRS/VEH/No AS, P<0.05; 
-31% vs. No CRS/VEH/AS, P<0.01; -27% vs. CRS/VEH/No AS, 
P<0.05) and in CRS rats treated with lurasidone (-23% vs. No 
CRS/VEH/No AS, P<0.05; -22% vs. CRS/VEH/No AS, P<0.05) 
(Fig.15B). 
Concerning Gpx4, in the dorsal hippocampus we observed a significant 
LUR x AS interaction (F1,65=5.358, P=0.0238). Specifically, the analysis 
highlighted a significant increase of Gpx4 following acute stress in not 
stressed and not treated animals (+31% vs. No CRS/VEH/No AS, 
P<0.01) that is not present in animals that received lurasidone (-27% 
vs. No CRS/VEH/AS, P<0.01) (Fig.15C). The analysis of Gpx4 
modulation in the ventral hippocampus revealed a significant effect of 
lurasidone (F1,68=8.525, P=0.0047) and of acute stress (F1,68=4.234, 
P=0.0435). Indeed, in rats not exposed to CRS, Gpx4 gene expression 
was up-regulated by acute stress only in animals that received 
lurasidone (+26% vs. No CRS/LUR/No AS, P<0.05). On the other hand, 
lurasidone was able to increase Gpx4 mRNA levels in CRS animals 
regardless acute stress exposure (+28% and +42% vs. CRS/VEH/No 
AS, P<0.05 and P<0.01 of CRS/LUR/No AS and CRS/LUR/AS 
respectively) (Fig.15D). 
The modulation of Mt-1a in the dorsal hippocampus partially reflects the 
profile of Srxn1. Indeed, as shown by the Three-way ANOVA analyses, 
Mt-1a was strongly influenced by acute stress (F1,66=13.80, P=0.0004) 
and by a CRS x AS interaction effect (F1,66=17.08, P=0.0001). Indeed, 
acute stress induced the expression of Mt-1a in not stressed rats (+56% 
vs. No CRS/VEH/No AS, P<0.001) and in not stressed rats treated with 
lurasidone (+44% vs. No CRS/VEH/No AS, P<0.01; +60% vs. No 
CRS/LUR/No AS, P<0.001). Interestingly, this acute up-regulation was 
absent in CRS rats (-29% vs. No CRS/VEH/AS, P<0.01) even in 
animals treated with lurasidone (-29% vs. No CRS/VEH/AS, P<0.01; -
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24% vs. No CRS/LUR/AS P<0.05) (Fig.15E). A partially similar profile 
was observed in the ventral hippocampus. The Three-way analysis 
depicted an effect of CRS (F1,70=11.54, P=0.0011, of AS (F1,70=6.272, 
P=0.0146) and a CRS x LUR x AS interaction (F1,70=4.350, P=0.0407). 
Acute stress increased Mt-1a in naïve animals (+22% vs. No 
CRS/VEH/No AS, P<0.05) but this effect could not be seen in animals 
previously exposed to CRS (-37% vs. No CRS/VEH/AS, P<0.001, -23% 
vs. No CRS/VEH/No AS, P<0.05). In this regard, lurasidone moderately 
restore the activation of Mt-1a by acute stress in CRS rats (+19% vs. 
CRS/LUR/No AS, P<0.05; +24% vs. CRS/VEH/AS, P<0.01) (Fig.15F). 
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Fig.15 Effect of acute stress exposure on the gene expression of Gpx1, 
Gpx4 and Mt-1a after 3 weeks of washout from CRS and lurasidone 
treatment 
The mRNA levels of Gpx1, Gpx4 and Mt-1a were measured in the 
dorsal (A, C, E) and ventral (B, D, F) hippocampus of not stressed (No 
CRS) and stressed (CRS) rats treated with vehicle (VEH) or lurasidone 
(LUR) and exposed after 3 weeks of washout to acute stress (AS) or not 
(No AS). The data, expressed as percentage of No CRS/VEH/No AS 
animals (set at 100%), are the mean ± SEM of independent 
determinations. *P<0.05, *P<0.01, ***P<0.001 vs. No CRS/VEH/No AS; 
##P<0.01, ###P<0.001 vs. No CRS/VEH/AS; £P<0.05, ££P<0.01, 
£££P<0.01 vs. No CRS/LUR/No AS; °P<0.05 vs. No CRS/LUR/AS; 
$P<0.05, $$P<0.01, $$$P<0.001 vs. CRS/VEH/No AS; @P<0.05 vs. 
CRS/LUR/No AS, ççP<0.01 vs. CRS/VEH/AS (Three-way ANOVA with 
Fisher’s LSD). 
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4.4.3 Discussion 
 
Despite the majority of depressed patients may achieve remission 
following successful pharmacological treatment, there is a high 
percentage who experience relapses and reoccurrences, usually as a 
consequence of environmental adversities. Furthermore, around 30% of 
the patients did not respond to pharmacological treatments (Vos et al., 
2004; Rush et al., 2006), underlying the need to identify novel therapies 
as well as new pharmacological targets to prevent further relapses.  
On these bases, we investigated the recovery effect of a post-stress 
period and the brain’s ability in reacting to a subsequent challenge, in 
order to identify long-lasting stress-induced changes, and to investigate 
the ability of lurasidone to improve such alterations. We firstly 
demonstrated that the molecular signatures produced by chronic 
restraint stress on redox regulators disappeared after 3 stress-free 
weeks. Indeed, after recovery, the alterations in the expression of Nox2 
and Nrf2 that we observed as a result of chronic mild stress exposure 
(Rossetti et al., 2018) were no longer detectable in the rat 
hippocampus. Further, except for Gpx1 in the dorsal hippocampus, also 
the analyses on other antioxidants did not highlight a long-lasting 
modulation attributable to CRS. Accordingly, different studies 
demonstrated that the hippocampus is able to spontaneously “recover” 
after chronic stress (Ortiz et al., 2014;Ortiz et al., 2018), supporting the 
adaptive properties of this brain region in re-establishing homeostasis.  
Nevertheless, the lack of effects observed after washout cannot exclude 
the possibility that previous CRS exposure may sensitize oxidative 
systems to environmental challenges, such as an acute stress. 
Supporting this theory, we observed that the modulation of Srxn1 and 
Mt-1a –especially the acute stress-induced up-regulation- was strongly 
influenced by the previous chronic stress exposure. Given the 
antioxidant function of Srxn1 and Mt-1a, involved in keeping the balance 
of the cell's oxidation/reduction, the up-regulation of their mRNA levels 
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after the acute stress could be seen as a beneficial adaptive reaction of 
the animal to this specific type of challenge that mimic a sudden difficult 
situation, a positive effect that is lessened by the previous exposure to a 
chronic stress. Despite this, we did not observe such a clear modulation 
of glutathione peroxidases. This could be the result of a different 
involvement and recruitment of such enzymes in the acute stress 
response. Indeed, Spiers and colleagues demonstrated that increases 
of Gpx1 and Gpx4 can be observed in the rat hippocampus after 4 
hours of immobilization, while weren’t detected after restraint paradigm 
of 2 or 1 hour, as ours (Spiers et al., 2016). 
Moreover, we highlighted the ability of a chronic pharmacological 
treatment with lurasidone in partially restoring the chronic stress-
impaired antioxidant up-regulation of Srxn1 and Mt-1a –an effect limited 
to the ventral hippocampus for Mt-1a- observed physiologically after 
acute stress.  
 
Our results suggest that chronic stress-induced oxidative damage may 
represent a key mechanism contributing to the risk of relapse and to the 
functional impairments that feature stress-related psychiatric disorders. 
Indeed, chronic stress left a long-lasting signature, still present after 3 
weeks of recovery, and impaired the acute challenge-induced trigger of 
the antioxidant machinery. Additionally, the results reveal the complexity 
of the dynamic mechanisms set in motion to cope with challenges, 
especially when the systems are already impaired, adding new 
information that should be further investigated to promote adaptive 
responses. Moreover, we provide new insights on the mechanism of 
action of lurasidone, which can partially restore the redox homeostasis 
after stress exposure and may ameliorate specific functions that are 
deteriorated in psychiatric patients.  
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5. Summary and Conclusions 
 
In conclusion, the results obtained during my PhD add new preclinical 
data about how a stress exposure can critically influence our upcoming 
body reactions to different stimuli. By using different experimental stress 
approaches, i.e. prenatal stress, social defeat and chronic stress, we 
strengthen the idea that stress can leave a “scar” in the individuals and 
affect the outcome of conditions that occur thereafter. Moreover, we 
brought new insights in the mechanisms set in motion by stress, 
identifying neuroinflammation, altered oxidative balance and impaired 
neuroplasticity as potential molecular targets underlying the long-term 
effects of adverse events. 
In the first 2 experiments, I took advantage of the prenatal stress 
paradigm, a model that allows to deepen the role of early life adversities 
in shaping a disordered brain. The obtained results showed that being 
affected by stress during gestation can increase the sensitivity to the 
EAE encephalomyelitis model of multiple sclerosis in adulthood. 
Moreover, underlying the more severe symptomatology, we identified 
alterations in the oligodendrocytes maturation in the spinal cord. Indeed, 
while during the chronic EAE phase not stressed mice displayed a 
physiological remyelination, prenatally stressed animals had increased 
level of GPR17, a marker of immature oligodendrocytes, suggesting 
that prenatal stress could alter the proper myelin repair during the 
recovery after the disease. Further, we identified alterations in the 
signaling of the neurotrophin BDNF in EAE mice exposed to stress, 
suggesting that the neurotrophin could be a target underlying the stress-
induced impaired remyelination.  
We next investigated the long-term effect of prenatal stress on the 
responsiveness to a further acute stress in adulthood. More in detail, 
after exposing prenatally stressed mice to a second challenge, I 
analyzed the physiological acute responsiveness of inflammatory 
markers and mediators of the oxidative balance. The analyses revealed 
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that fetal stress exposure increased pro-inflammatory and decreased 
anti-inflammatory cytokines gene expression in the hippocampus, and 
altered the acute stress modulation of mediators of the oxidative 
balance. Indeed, once exposed to the second challenge, prenatally 
stressed mice displayed greater and more lasting nuclear translocation 
of nuclear factor-like 2 (Nrf-2), a master regulator of the anti-oxidant 
response, compared to non-stressed animals. However, Nrf-2 up-
regulation failed to restore and reactivate the hyperoxidized form of 
peroxiredoxins (Prxs), which levels are sensitive indicators of oxidative 
damage. These results suggest that the adaptive mechanisms 
orchestrated after an acute challenge are in some extent influenced by 
prenatal stress, and that the physiological re-establishment of 
homeostasis is impaired by the exposure to early-life adversities. 
In the third part of the project I investigated the effect of social stress, a 
critical feature of adolescence, the period marking the transition from 
childhood to adulthood. Indeed, adolescence is known to be peculiarly 
sensitive to the environment and psychosocial stress, such as bullying 
or subordination, is strongly related to an enhanced vulnerability to 
psychological morbidities later in adulthood (Jaworska and MacQueen, 
2015; Lupien et al., 2009; Romeo & McEwen, 2006). During the 6 
months that I spent at the laboratory of Brain Injury, Neuroinflammation 
and Cognitive Function headed by Professor Susanna Rosi at the 
University of California, San Francisco, I exposed adolescent male mice 
to the social defeat stress protocol and then to two mild concussions 
using a recently developed experimental model of traumatic brain injury 
(TBI), the repetitive closed-head impact model of engineered rotational 
acceleration (CHIMERA). The results highlighted that stressed mice 
developed anxiety-like features, regardless the concussions, while 
stress and brain injury have a reciprocal influence in the NOR test, 
where only mice that were both stressed and exposed to TBI did not 
display impairment in the ability to recognized the novel object. In 
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parallel to these behavioral –hippocampal-dependent- evaluations I 
investigated the possible involvement of neuroinflammation in the 
hippocampus, without finding any difference in microglia activation 
between the experimental conditions. 
In the last part of the thesis, I investigated the long-term effects of the 
chronic restraint (CRS) paradigm, a well-established animal model of 
stress-related psychiatric diseases, on the redox homeostasis in the 
adult rat hippocampus. Specifically, I studied if chronic stress can leave 
a molecular signature that could still be observed after a recovery of 3 
weeks and how this “trace” could alter the responsiveness to a second 
acute challenge. The molecular analyses targeted modulators of the 
oxidative balance, recognized to have a role in the etiology of mental 
diseases, and demonstrated that acute stress strongly induced the gene 
expression of Srxn1 and Mt-1a, two antioxidant enzymes. This 
beneficial effect carried out to cope with a sudden challenging situation 
was impaired by the previous exposure to chronic stress. Interestingly, 
chronic lurasidone treatment partially restored the appropriate acute 
responsiveness. Our results suggest that chronic stress-induced 
oxidative damage may have a critical role in the impaired acute 
responsiveness that features stress-related psychiatric disorders, and 
give new insights on the therapeutic mechanism of action of lurasidone. 
 
Since the concept of personalized medicine is becoming more and 
more acknowledged, the need of taking into account previous 
environmental stressors in managing patients’ therapies is growing in 
importance. In this context, my results provide new evidence about 
possible mechanisms by which stress can prone the individual to be 
differently susceptible to further adverse events.		
  
114 	
6. Bibliography 
 
Acosta, C. M., Cortes, C., MacPhee, H. and Namaka, M. P. (2013) 
'Exploring the role of nerve growth factor in multiple sclerosis: 
implications in myelin repair', CNS Neurol Disord Drug Targets, 12(8), 
1242-56. 
 
Al-Harbi, K. S. (2012) 'Treatment-resistant depression: therapeutic 
trends, challenges, and future directions', Patient Prefer Adherence, 6, 
369-88. 
 
Alexander, B. T., Dasinger, J. H. and Intapad, S. (2015) 'Fetal 
programming and cardiovascular pathology', Compr Physiol, 5(2), 997-
1025. 
 
An, J. J., Gharami, K., Liao, G. Y., Woo, N. H., Lau, A. G., Vanevski, F., 
Torre, E. R., Jones, K. R., Feng, Y., Lu, B. and Xu, B. (2008) 'Distinct 
role of long 3' UTR BDNF mRNA in spine morphology and synaptic 
plasticity in hippocampal neurons', Cell, 134(1), 175-87. 
 
Anacker, C. and Hen, R. (2017) 'Adult hippocampal neurogenesis and 
cognitive flexibility - linking memory and mood', Nat Rev Neurosci, 
18(6), 335-346. 
 
Assary, E., Vincent, J. P., Keers, R. and Pluess, M. (2018) 'Gene-
environment interaction and psychiatric disorders: Review and future 
directions', Semin Cell Dev Biol, 77, 133-143. 
 
Autry, A. E. and Monteggia, L. M. (2012) 'Brain-derived neurotrophic 
factor and neuropsychiatric disorders', Pharmacol Rev, 64(2), 238-58. 
 
115 	
Baj, G., Leone, E., Chao, M. V. and Tongiorgi, E. (2011) 'Spatial 
segregation of BDNF transcripts enables BDNF to differentially shape 
distinct dendritic compartments', Proc Natl Acad Sci U S A, 108(40), 
16813-8. 
 
Barker, D. J. (1998) 'In utero programming of chronic disease', Clin Sci 
(Lond), 95(2), 115-28. 
 
Barton, G. M. (2008) 'A calculated response: control of inflammation by 
the innate immune system', J Clin Invest, 118(2), 413-20. 
 
Bernstein, C. N. (2017) 'The Brain-Gut Axis and Stress in Inflammatory 
Bowel Disease', Gastroenterol Clin North Am, 46(4), 839-846. 
 
Blaze, J., Asok, A., Borrelli, K., Tulbert, C., Bollinger, J., Ronca, A. E. 
and Roth, T. L. (2017) 'Intrauterine exposure to maternal stress alters 
Bdnf IV DNA methylation and telomere length in the brain of adult rat 
offspring', Int J Dev Neurosci, 62, 56-62. 
 
Blugeot, A., Rivat, C., Bouvier, E., Molet, J., Mouchard, A., Zeau, B., 
Bernard, C., Benoliel, J. J. and Becker, C. (2011) 'Vulnerability to 
depression: from brain neuroplasticity to identification of biomarkers', J 
Neurosci, 31(36), 12889-99. 
 
Bock, J., Breuer, S., Poeggel, G. and Braun, K. (2017) 'Early life stress 
induces attention-deficit hyperactivity disorder (ADHD)-like behavioral 
and brain metabolic dysfunctions: functional imaging of methylphenidate 
treatment in a novel rodent model', Brain Struct Funct, 222(2), 765-780. 
 
Bodnar, C. N., Roberts, K. N., Higgins, E. K. and Bachstetter, A. D. 
(2019) 'A Systematic Review of Closed Head Injury Models of Mild 
116 	
Traumatic Brain Injury in Mice and Rats', J Neurotrauma, 36(11), 1683-
1706. 
 
Boersma, G. J., Lee, R. S., Cordner, Z. A., Ewald, E. R., Purcell, R. H., 
Moghadam, A. A. and Tamashiro, K. L. (2014) 'Prenatal stress 
decreases Bdnf expression and increases methylation of Bdnf exon IV 
in rats', Epigenetics, 9(3), 437-47. 
 
Bondar, N. P. and Merkulova, T. I. (2016) 'Brain-derived neurotrophic 
factor and early-life stress: Multifaceted interplay', J Biosci, 41(4), 751-
758. 
 
Borders, A. A., Aly, M., Parks, C. M. and Yonelinas, A. P. (2017) 'The 
hippocampus is particularly important for building associations across 
stimulus domains', Neuropsychologia, 99, 335-342. 
 
Bouvier, E., Brouillard, F., Molet, J., Claverie, D., Cabungcal, J. H., 
Cresto, N., Doligez, N., Rivat, C., Do, K. Q., Bernard, C., Benoliel, J. J. 
and Becker, C. (2017) 'Nrf2-dependent persistent oxidative stress 
results in stress-induced vulnerability to depression', Mol Psychiatry, 
22(12), 1795. 
 
Bramlett, H. M. and Dietrich, W. D. (2015) 'Long-Term Consequences 
of Traumatic Brain Injury: Current Status of Potential Mechanisms of 
Injury and Neurological Outcomes', J Neurotrauma, 32(23), 1834-48. 
 
Briones-Buixassa, L., Milà, R., Mª Aragonès, J., Bufill, E., Olaya, B. and 
Arrufat, F. X. (2015) 'Stress and multiple sclerosis: A systematic review 
considering potential moderating and mediating factors and methods of 
assessing stress', Health Psychol Open, 2(2), 2055102915612271. 
 
117 	
Briscoe, L., Lavender, T. and McGowan, L. (2016) 'A concept analysis 
of women's vulnerability during pregnancy, birth and the postnatal 
period', J Adv Nurs, 72(10), 2330-45. 
 
Bryant, R. (2011) 'Post-traumatic stress disorder vs traumatic brain 
injury', Dialogues Clin Neurosci, 13(3), 251-62. 
 
Burcusa, S. L. and Iacono, W. G. (2007) 'Risk for recurrence in 
depression', Clin Psychol Rev, 27(8), 959-85. 
 
Buwalda, B., Geerdink, M., Vidal, J. and Koolhaas, J. M. (2011) 'Social 
behavior and social stress in adolescence: a focus on animal models', 
Neurosci Biobehav Rev, 35(8), 1713-21. 
 
Calabrese, F., Rossetti, A. C., Racagni, G., Gass, P., Riva, M. A. and 
Molteni, R. (2014) 'Brain-derived neurotrophic factor: a bridge between 
inflammation and neuroplasticity', Front Cell Neurosci, 8, 430. 
 
Calcia, M. A., Bonsall, D. R., Bloomfield, P. S., Selvaraj, S., Barichello, 
T. and Howes, O. D. (2016) 'Stress and neuroinflammation: a 
systematic review of the effects of stress on microglia and the 
implications for mental illness', Psychopharmacology (Berl), 233(9), 
1637-50. 
 
Casaril, A. M., Domingues, M., Bampi, S. R., de Andrade Lourenço, D., 
Padilha, N. B., Lenardão, E. J., Sonego, M., Seixas, F. K., Collares, T., 
Nogueira, C. W., Dantzer, R. and Savegnago, L. (2019) 'The selenium-
containing compound 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole 
reverses depressive-like behavior induced by acute restraint stress in 
mice: modulation of oxido-nitrosative stress and inflammatory pathway', 
Psychopharmacology (Berl). 
118 	
 
Case, L. K., Del Rio, R., Bonney, E. A., Zachary, J. F., Blankenhorn, E. 
P., Tung, K. S. and Teuscher, C. (2010) 'The postnatal maternal 
environment affects autoimmune disease susceptibility in A/J mice', Cell 
Immunol, 260(2), 119-27. 
 
Casey, B. J., Jones, R. M. and Hare, T. A. (2008) 'The adolescent 
brain', Ann N Y Acad Sci, 1124, 111-26. 
 
Caspi, A. and Moffitt, T. E. (2006) 'Gene-environment interactions in 
psychiatry: joining forces with neuroscience', Nat Rev Neurosci, 7(7), 
583-90. 
 
Cattaneo, A. and Riva, M. A. (2016) 'Stress-induced mechanisms in 
mental illness: A role for glucocorticoid signalling', J Steroid Biochem 
Mol Biol, 160, 169-74. 
 
Chandler, N., Jacobson, S., Esposito, P., Connolly, R. and Theoharides, 
T. C. (2002) 'Acute stress shortens the time to onset of experimental 
allergic encephalomyelitis in SJL/J mice', Brain Behav Immun, 16(6), 
757-63. 
 
Chandran, A., Iyo, A. H., Jernigan, C. S., Legutko, B., Austin, M. C. and 
Karolewicz, B. (2013) 'Reduced phosphorylation of the mTOR signaling 
pathway components in the amygdala of rats exposed to chronic 
stress', Prog Neuropsychopharmacol Biol Psychiatry, 40, 240-5. 
 
Chao, M. V. and Hempstead, B. L. (1995) 'p75 and Trk: a two-receptor 
system', Trends Neurosci, 18(7), 321-6. 
 
119 	
Chen, H., Huang, Q., Zhang, S., Hu, K., Xiong, W., Xiao, L., Cong, R., 
Liu, Q. and Wang, Z. (2019) 'The Chinese Herbal Formula PAPZ 
Ameliorates Behavioral Abnormalities in Depressive Mice', Nutrients, 
11(4). 
 
Chen, Y., Wu, H., Wang, S., Koito, H., Li, J., Ye, F., Hoang, J., Escobar, 
S. S., Gow, A., Arnett, H. A., Trapp, B. D., Karandikar, N. J., Hsieh, J. 
and Lu, Q. R. (2009) 'The oligodendrocyte-specific G protein-coupled 
receptor GPR17 is a cell-intrinsic timer of myelination', Nat Neurosci, 
12(11), 1398-406. 
 
Chiba, S., Numakawa, T., Ninomiya, M., Richards, M. C., Wakabayashi, 
C. and Kunugi, H. (2012) 'Chronic restraint stress causes anxiety- and 
depression-like behaviors, downregulates glucocorticoid receptor 
expression, and attenuates glutamate release induced by brain-derived 
neurotrophic factor in the prefrontal cortex', Prog 
Neuropsychopharmacol Biol Psychiatry, 39(1), 112-9. 
 
Chowdhury, S., Shepherd, J. D., Okuno, H., Lyford, G., Petralia, R. S., 
Plath, N., Kuhl, D., Huganir, R. L. and Worley, P. F. (2006) 'Arc/Arg3.1 
interacts with the endocytic machinery to regulate AMPA receptor 
trafficking', Neuron, 52(3), 445-59. 
 
Cobley, J. N., Fiorello, M. L. and Bailey, D. M. (2018) '13 reasons why 
the brain is susceptible to oxidative stress', Redox Biol, 15, 490-503. 
 
Coe, C. L. and Lubach, G. R. (2005) 'Prenatal origins of individual 
variation in behavior and immunity', Neurosci Biobehav Rev, 29(1), 39-
49. 
 
120 	
Collaborators, G. N. (2019) 'Global, regional, and national burden of 
neurological disorders, 1990-2016: a systematic analysis for the Global 
Burden of Disease Study 2016', Lancet Neurol, 18(5), 459-480. 
 
Columba-Cabezas, S., Iaffaldano, G., Chiarotti, F., Alleva, E. and Cirulli, 
F. (2009) 'Early handling increases susceptibility to experimental 
autoimmune encephalomyelitis (EAE) in C57BL/6 male mice', J 
Neuroimmunol, 212(1-2), 10-6. 
 
Conradi, S., Malzahn, U., Paul, F., Quill, S., Harms, L., Then Bergh, F., 
Ditzenbach, A., Georgi, T., Heuschmann, P. and Rosche, B. (2013) 
'Breastfeeding is associated with lower risk for multiple sclerosis', Mult 
Scler, 19(5), 553-8. 
 
Coppolino, G. T., Marangon, D., Negri, C., Menichetti, G., Fumagalli, 
M., Gelosa, P., Dimou, L., Furlan, R., Lecca, D. and Abbracchio, M. P. 
(2018) 'Differential local tissue permissiveness influences the final fate 
of GPR17-expressing oligodendrocyte precursors in two distinct models 
of demyelination', Glia, 66(5), 1118-1130. 
 
Cui, Z., Zhong, Z., Yang, Y., Wang, B., Sun, Y., Sun, Q., Yang, G. Y. 
and Bian, L. (2016) 'Ferrous Iron Induces Nrf2 Expression in Mouse 
Brain Astrocytes to Prevent Neurotoxicity', J Biochem Mol Toxicol, 
30(8), 396-403. 
 
Darnaudéry, M. and Maccari, S. (2008) 'Epigenetic programming of the 
stress response in male and female rats by prenatal restraint stress', 
Brain Res Rev, 57(2), 571-85. 
 
Davis, M. T., Holmes, S. E., Pietrzak, R. H. and Esterlis, I. (2017) 
'Neurobiology of Chronic Stress-Related Psychiatric Disorders: 
121 	
Evidence from Molecular Imaging Studies', Chronic Stress (Thousand 
Oaks), 1. 
 
De Santi, L., Annunziata, P., Sessa, E. and Bramanti, P. (2009) 'Brain-
derived neurotrophic factor and TrkB receptor in experimental 
autoimmune encephalomyelitis and multiple sclerosis', J Neurol Sci, 
287(1-2), 17-26. 
 
Deuschle, M., Hendlmeier, F., Witt, S., Rietschel, M., Gilles, M., 
Sánchez-Guijo, A., Fañanas, L., Hentze, S., Wudy, S. A. and Hellweg, 
R. (2018) 'Cortisol, cortisone, and BDNF in amniotic fluid in the second 
trimester of pregnancy: Effect of early life and current maternal stress 
and socioeconomic status', Dev Psychopathol, 30(3), 971-980. 
 
Dibble, C. C. and Cantley, L. C. (2015) 'Regulation of mTORC1 by PI3K 
signaling', Trends Cell Biol, 25(9), 545-55. 
 
Dimitrijević, M., Laban, O., von Hoersten, S., Marković, B. M. and 
Janković, B. D. (1994) 'Neonatal sound stress and development of 
experimental allergic encephalomyelitis in Lewis and DA rats', Int J 
Neurosci, 78(1-2), 135-43. 
 
Diz-Chaves, Y., Astiz, M., Bellini, M. J. and Garcia-Segura, L. M. (2013) 
'Prenatal stress increases the expression of proinflammatory cytokines 
and exacerbates the inflammatory response to LPS in the hippocampal 
formation of adult male mice', Brain Behav Immun, 28, 196-206. 
 
Donat, C. K., Scott, G., Gentleman, S. M. and Sastre, M. (2017) 
'Microglial Activation in Traumatic Brain Injury', Front Aging Neurosci, 9, 
208. 
 
122 	
Entringer, S., Buss, C. and Wadhwa, P. D. (2015) 'Prenatal stress, 
development, health and disease risk: A psychobiological perspective-
2015 Curt Richter Award Paper', Psychoneuroendocrinology, 62, 366-
75. 
 
Faa, G., Manchia, M., Pintus, R., Gerosa, C., Marcialis, M. A. and 
Fanos, V. (2016) 'Fetal programming of neuropsychiatric disorders', 
Birth Defects Res C Embryo Today, 108(3), 207-223. 
 
Fancy, S. P., Kotter, M. R., Harrington, E. P., Huang, J. K., Zhao, C., 
Rowitch, D. H. and Franklin, R. J. (2010) 'Overcoming remyelination 
failure in multiple sclerosis and other myelin disorders', Exp Neurol, 
225(1), 18-23. 
 
Fioranelli, M., Bottaccioli, A. G., Bottaccioli, F., Bianchi, M., Rovesti, M. 
and Roccia, M. G. (2018) 'Stress and Inflammation in Coronary Artery 
Disease: A Review Psychoneuroendocrineimmunology-Based', Front 
Immunol, 9, 2031. 
 
Fonzo, G. A., Ramsawh, H. J., Flagan, T. M., Simmons, A. N., Sullivan, 
S. G., Allard, C. B., Paulus, M. P. and Stein, M. B. (2016) 'Early life 
stress and the anxious brain: evidence for a neural mechanism linking 
childhood emotional maltreatment to anxiety in adulthood', Psychol 
Med, 46(5), 1037-54. 
 
Frasch, M. G., Lobmaier, S. M., Stampalija, T., Desplats, P., Pallarés, 
M. E., Pastor, V., Brocco, M. A., Wu, H. T., Schulkin, J., Herry, C. L., 
Seely, A. J. E., Metz, G. A. S., Louzoun, Y. and Antonelli, M. C. (2018) 
'Non-invasive biomarkers of fetal brain development reflecting prenatal 
stress: An integrative multi-scale multi-species perspective on data 
collection and analysis', Neurosci Biobehav Rev. 
123 	
 
Fraunberger, E. A., Scola, G., Laliberté, V. L., Duong, A. and 
Andreazza, A. C. (2016) 'Redox Modulations, Antioxidants, and 
Neuropsychiatric Disorders', Oxid Med Cell Longev, 2016, 4729192. 
 
Fuchs, E. and Flügge, G. (2014) 'Adult neuroplasticity: more than 40 
years of research', Neural Plast, 2014, 541870. 
 
Fumagalli, M., Bonfanti, E., Daniele, S., Zappelli, E., Lecca, D., Martini, 
C., Trincavelli, M. L. and Abbracchio, M. P. (2015) 'The ubiquitin ligase 
Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G 
protein-coupled receptor kinase 2 in the regulation of GPR17 receptor 
desensitization', Glia, 63(12), 2327-39. 
 
Fumagalli, M., Lecca, D., Coppolino, G. T., Parravicini, C. and 
Abbracchio, M. P. (2017) 'Pharmacological Properties and Biological 
Functions of the GPR17 Receptor, a Potential Target for Neuro-
Regenerative Medicine', Adv Exp Med Biol, 1051, 169-192. 
 
Galli, F., Piroddi, M., Annetti, C., Aisa, C., Floridi, E. and Floridi, A. 
(2005) 'Oxidative stress and reactive oxygen species', Contrib Nephrol, 
149, 240-260. 
 
Gao, W., Wang, W., Peng, Y. and Deng, Z. (2019) 'Antidepressive 
effects of kaempferol mediated by reduction of oxidative stress, 
proinflammatory cytokines and up-regulation of AKT/β-catenin cascade', 
Metab Brain Dis, 34(2), 485-494. 
 
Gardener, H., Munger, K. L., Chitnis, T., Michels, K. B., Spiegelman, D. 
and Ascherio, A. (2009) 'Prenatal and perinatal factors and risk of 
multiple sclerosis', Epidemiology, 20(4), 611-8. 
124 	
 
Giedd, J. N. and Rapoport, J. L. (2010) 'Structural MRI of pediatric brain 
development: what have we learned and where are we going?', Neuron, 
67(5), 728-34. 
 
Golden, S. A., Covington, H. E., Berton, O. and Russo, S. J. (2011) 'A 
standardized protocol for repeated social defeat stress in mice', Nat 
Protoc, 6(8), 1183-91. 
 
Gradus, J. L. (2017) 'Prevalence and prognosis of stress disorders: a 
review of the epidemiologic literature', Clin Epidemiol, 9, 251-260. 
 
Gray, J. D., Milner, T. A. and McEwen, B. S. (2013) 'Dynamic plasticity: 
the role of glucocorticoids, brain-derived neurotrophic factor and other 
trophic factors', Neuroscience, 239, 214-27. 
 
Guardiola-Diaz, H. M., Ishii, A. and Bansal, R. (2012) 'Erk1/2 MAPK and 
mTOR signaling sequentially regulates progression through distinct 
stages of oligodendrocyte differentiation', Glia, 60(3), 476-86. 
 
Hanisch, U. K. and Kettenmann, H. (2007) 'Microglia: active sensor and 
versatile effector cells in the normal and pathologic brain', Nat Neurosci, 
10(11), 1387-94. 
 
Harbo, H. F., Gold, R. and Tintoré, M. (2013) 'Sex and gender issues in 
multiple sclerosis', Ther Adv Neurol Disord, 6(4), 237-48. 
 
Harris, M. L., Oldmeadow, C., Hure, A., Luu, J., Loxton, D. and Attia, J. 
(2017) 'Stress increases the risk of type 2 diabetes onset in women: A 
12-year longitudinal study using causal modelling', PLoS One, 12(2), 
e0172126. 
125 	
 
Hassan, W., Noreen, H., Castro-Gomes, V., Mohammadzai, I., da 
Rocha, J. B. and Landeira-Fernandez, J. (2016) 'Association of 
Oxidative Stress with Psychiatric Disorders', Curr Pharm Des, 22(20), 
2960-74. 
 
Hata, T., Nishikawa, H., Itoh, E. and Funakami, Y. (2001) 'Anxiety-like 
behavior in elevated plus-maze tests in repeatedly cold-stressed mice', 
Jpn J Pharmacol, 85(2), 189-96. 
 
Heesen, C., Gold, S. M., Huitinga, I. and Reul, J. M. (2007) 'Stress and 
hypothalamic-pituitary-adrenal axis function in experimental 
autoimmune encephalomyelitis and multiple sclerosis - a review', 
Psychoneuroendocrinology, 32(6), 604-18. 
 
Hohmann, C. F., Odebode, G., Naidu, L. and Koban, M. (2017) 'Early 
Life Stress Alters Adult Inflammatory Responses in a Mouse Model for 
Depression', Ann Psychiatry Ment Health, 5(2). 
 
Hollis, F. and Kabbaj, M. (2014) 'Social defeat as an animal model for 
depression', ILAR J, 55(2), 221-32. 
 
Jaworska, N. and MacQueen, G. (2015) 'Adolescence as a unique 
developmental period', J Psychiatry Neurosci, 40(5), 291-3. 
 
Joëls, M. and Krugers, H. J. (2007) 'LTP after stress: up or down?', 
Neural Plast, 2007, 93202. 
 
Joëls, M., Pu, Z., Wiegert, O., Oitzl, M. S. and Krugers, H. J. (2006) 
'Learning under stress: how does it work?', Trends Cogn Sci, 10(4), 
152-8. 
126 	
 
Justice, N. J. (2018) 'The relationship between stress and Alzheimer's 
disease', Neurobiol Stress, 8, 127-133. 
 
Kelly, R. R., McDonald, L. T., Jensen, N. R., Sidles, S. J. and LaRue, A. 
C. (2019) 'Impacts of Psychological Stress on Osteoporosis: Clinical 
Implications and Treatment Interactions', Front Psychiatry, 10, 200. 
 
Kelly, S. J. and Ismail, M. (2015) 'Stress and type 2 diabetes: a review 
of how stress contributes to the development of type 2 diabetes', Annu 
Rev Public Health, 36, 441-62. 
 
Kertes, D. A., Bhatt, S. S., Kamin, H. S., Hughes, D. A., Rodney, N. C. 
and Mulligan, C. J. (2017) 'methylation in mothers and newborns is 
associated with maternal exposure to war trauma', Clin Epigenetics, 9, 
68. 
 
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., 
Merikangas, K. R., Rush, A. J., Walters, E. E., Wang, P. S. and 
Replication, N. C. S. (2003) 'The epidemiology of major depressive 
disorder: results from the National Comorbidity Survey Replication 
(NCS-R)', JAMA, 289(23), 3095-105. 
 
Kim, E. J., Pellman, B. and Kim, J. J. (2015) 'Stress effects on the 
hippocampus: a critical review', Learn Mem, 22(9), 411-6. 
 
Kimbler, D. E., Murphy, M. and Dhandapani, K. M. (2011) 'Concussion 
and the adolescent athlete', J Neurosci Nurs, 43(6), 286-90. 
 
127 	
Konturek, P. C., Brzozowski, T. and Konturek, S. J. (2011) 'Stress and 
the gut: pathophysiology, clinical consequences, diagnostic approach 
and treatment options', J Physiol Pharmacol, 62(6), 591-9. 
 
Krementsov, D. N. and Teuscher, C. (2013) 'Environmental factors 
acting during development to influence MS risk: insights from animal 
studies', Mult Scler, 19(13), 1684-9. 
 
Krishnan, V. and Nestler, E. J. (2008) 'The molecular neurobiology of 
depression', Nature, 455(7215), 894-902. 
 
Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J. and Maes, M. 
(2011) 'In animal models, psychosocial stress-induced 
(neuro)inflammation, apoptosis and reduced neurogenesis are 
associated to the onset of depression', Prog Neuropsychopharmacol 
Biol Psychiatry, 35(3), 744-59. 
 
Kwon, E. J. and Kim, Y. J. (2017) 'What is fetal programming?: a 
lifetime health is under the control of in utero health', Obstet Gynecol 
Sci, 60(6), 506-519. 
 
Laban, O., Marković, B. M., Dimitrijević, M. and Janković, B. D. (1995) 
'Maternal deprivation and early weaning modulate experimental allergic 
encephalomyelitis in the rat', Brain Behav Immun, 9(1), 9-19. 
 
Lau, C., Rogers, J. M., Desai, M. and Ross, M. G. (2011) 'Fetal 
programming of adult disease: implications for prenatal care', Obstet 
Gynecol, 117(4), 978-85. 
 
128 	
Lee, P. R., Brady, D. and Koenig, J. I. (2003) 'Corticosterone alters N-
methyl-D-aspartate receptor subunit mRNA expression before puberty', 
Brain Res Mol Brain Res, 115(1), 55-62. 
 
Lesage, J., Del-Favero, F., Leonhardt, M., Louvart, H., Maccari, S., 
Vieau, D. and Darnaudery, M. (2004) 'Prenatal stress induces 
intrauterine growth restriction and programmes glucose intolerance and 
feeding behaviour disturbances in the aged rat', J Endocrinol, 181(2), 
291-6. 
 
Linker, R. A., Lee, D. H., Demir, S., Wiese, S., Kruse, N., Siglienti, I., 
Gerhardt, E., Neumann, H., Sendtner, M., Lühder, F. and Gold, R. 
(2010a) 'Functional role of brain-derived neurotrophic factor in 
neuroprotective autoimmunity: therapeutic implications in a model of 
multiple sclerosis', Brain, 133(Pt 8), 2248-63. 
 
Loebrich, S. and Nedivi, E. (2009) 'The function of activity-regulated 
genes in the nervous system', Physiol Rev, 89(4), 1079-103. 
 
Lu, C., Dong, L., Zhou, H., Li, Q., Huang, G., Bai, S. J. and Liao, L. 
(2018) 'G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte 
Differentiation in Response to Lysolecithin-Induced Demyelination', Sci 
Rep, 8(1), 4502. 
 
Luoni, A., Berry, A., Calabrese, F., Capoccia, S., Bellisario, V., Gass, 
P., Cirulli, F. and Riva, M. A. (2014a) 'Delayed BDNF alterations in the 
prefrontal cortex of rats exposed to prenatal stress: preventive effect of 
lurasidone treatment during adolescence', Eur Neuropsychopharmacol, 
24(6), 986-95. 
 
129 	
Luoni, A., Berry, A., Raggi, C., Bellisario, V., Cirulli, F. and Riva, M. A. 
(2016) 'Sex-Specific Effects of Prenatal Stress on Bdnf Expression in 
Response to an Acute Challenge in Rats: a Role for Gadd45β', Mol 
Neurobiol, 53(10), 7037-7047. 
 
Luoni, A., Macchi, F., Papp, M., Molteni, R. and Riva, M. A. (2014b) 
'Lurasidone exerts antidepressant properties in the chronic mild stress 
model through the regulation of synaptic and neuroplastic mechanisms 
in the rat prefrontal cortex', Int J Neuropsychopharmacol, 18(4). 
 
Luoni, A., Richetto, J., Racagni, G. and Molteni, R. (2015) 'The long-
term impact of early adversities on psychiatric disorders: focus on 
neuronal plasticity', Curr Pharm Des, 21(11), 1388-95. 
 
Lupien, S. J., McEwen, B. S., Gunnar, M. R. and Heim, C. (2009) 
'Effects of stress throughout the lifespan on the brain, behaviour and 
cognition', Nat Rev Neurosci, 10(6), 434-45. 
 
Machado-Vieira, R., Baumann, J., Wheeler-Castillo, C., Latov, D., 
Henter, I. D., Salvadore, G. and Zarate, C. A. (2010) 'The Timing of 
Antidepressant Effects: A Comparison of Diverse Pharmacological and 
Somatic Treatments', Pharmaceuticals (Basel), 3(1), 19-41. 
 
Maghzi, A. H., Etemadifar, M., Heshmat-Ghahdarijani, K., Nonahal, S., 
Minagar, A. and Moradi, V. (2012) 'Cesarean delivery may increase the 
risk of multiple sclerosis', Mult Scler, 18(4), 468-71. 
 
Majidi-Zolbanin, J., Doosti, M. H., Kosari-Nasab, M. and Salari, A. A. 
(2015) 'Prenatal maternal immune activation increases anxiety- and 
depressive-like behaviors in offspring with experimental autoimmune 
encephalomyelitis', Neuroscience, 294, 69-81. 
130 	
 
Makar, T. K., Bever, C. T., Singh, I. S., Royal, W., Sahu, S. N., Sura, T. 
P., Sultana, S., Sura, K. T., Patel, N., Dhib-Jalbut, S. and Trisler, D. 
(2009) 'Brain-derived neurotrophic factor gene delivery in an animal 
model of multiple sclerosis using bone marrow stem cells as a vehicle', 
J Neuroimmunol, 210(1-2), 40-51. 
 
Makar, T. K., Trisler, D., Sura, K. T., Sultana, S., Patel, N. and Bever, C. 
T. (2008) 'Brain derived neurotrophic factor treatment reduces 
inflammation and apoptosis in experimental allergic encephalomyelitis', 
J Neurol Sci, 270(1-2), 70-6. 
 
Markham, J. A. and Koenig, J. I. (2011) 'Prenatal stress: role in 
psychotic and depressive diseases', Psychopharmacology (Berl), 
214(1), 89-106. 
 
McCormick, C. M. and Green, M. R. (2013) 'From the stressed 
adolescent to the anxious and depressed adult: investigations in rodent 
models', Neuroscience, 249, 242-57. 
 
McEwen, B. S. (1998) 'Stress, adaptation, and disease. Allostasis and 
allostatic load', Ann N Y Acad Sci, 840, 33-44. 
 
McEwen, B. S., Bowles, N. P., Gray, J. D., Hill, M. N., Hunter, R. G., 
Karatsoreos, I. N. and Nasca, C. (2015) 'Mechanisms of stress in the 
brain', Nat Neurosci, 18(10), 1353-63. 
 
McKim, D. B., Niraula, A., Tarr, A. J., Wohleb, E. S., Sheridan, J. F. and 
Godbout, J. P. (2016a) 'Neuroinflammatory Dynamics Underlie Memory 
Impairments after Repeated Social Defeat', J Neurosci, 36(9), 2590-
604. 
131 	
 
Medzhitov, R. (2007) 'Recognition of microorganisms and activation of 
the immune response', Nature, 449(7164), 819-26. 
 
Mirzaei, F., Michels, K. B., Munger, K., O'Reilly, E., Chitnis, T., Forman, 
M. R., Giovannucci, E., Rosner, B. and Ascherio, A. (2011) 'Gestational 
vitamin D and the risk of multiple sclerosis in offspring', Ann Neurol, 
70(1), 30-40. 
 
Modgil, S., Lahiri, D. K., Sharma, V. L. and Anand, A. (2014) 'Role of 
early life exposure and environment on neurodegeneration: implications 
on brain disorders', Transl Neurodegener, 3, 9. 
 
Molteni, R., Calabrese, F., Cattaneo, A., Mancini, M., Gennarelli, M., 
Racagni, G. and Riva, M. A. (2009) 'Acute stress responsiveness of the 
neurotrophin BDNF in the rat hippocampus is modulated by chronic 
treatment with the antidepressant duloxetine', 
Neuropsychopharmacology, 34(6), 1523-32. 
 
Molteni, R., Rossetti, A. C., Savino, E., Racagni, G. and Calabrese, F. 
(2016) 'Chronic Mild Stress Modulates Activity-Dependent Transcription 
of BDNF in Rat Hippocampal Slices', Neural Plast, 2016, 2592319. 
 
Murray, P. S. and Holmes, P. V. (2011) 'An overview of brain-derived 
neurotrophic factor and implications for excitotoxic vulnerability in the 
hippocampus', Int J Pept, 2011, 654085. 
 
Namjoshi, D. R., Cheng, W. H., Bashir, A., Wilkinson, A., Stukas, S., 
Martens, K. M., Whyte, T., Abebe, Z. A., McInnes, K. A., Cripton, P. A. 
and Wellington, C. L. (2017) 'Defining the biomechanical and biological 
threshold of murine mild traumatic brain injury using CHIMERA (Closed 
132 	
Head Impact Model of Engineered Rotational Acceleration)', Exp 
Neurol, 292, 80-91. 
 
Ng, F., Berk, M., Dean, O. and Bush, A. I. (2008) 'Oxidative stress in 
psychiatric disorders: evidence base and therapeutic implications', Int J 
Neuropsychopharmacol, 11(6), 851-76. 
 
Nielsen, N. M., Bager, P., Stenager, E., Pedersen, B. V., Koch-
Henriksen, N., Hjalgrim, H. and Frisch, M. (2013) 'Cesarean section and 
offspring's risk of multiple sclerosis: a Danish nationwide cohort study', 
Mult Scler, 19(11), 1473-7. 
 
Nolan, A., Hennessy, E., Krukowski, K., Guglielmetti, C., Chaumeil, M. 
M., Sohal, V. S. and Rosi, S. (2018) 'Repeated Mild Head Injury Leads 
to Wide-Ranging Deficits in Higher-Order Cognitive Functions 
Associated with the Prefrontal Cortex', J Neurotrauma, 35(20), 2425-
2434. 
 
Numakawa, T., Suzuki, S., Kumamaru, E., Adachi, N., Richards, M. and 
Kunugi, H. (2010) 'BDNF function and intracellular signaling in neurons', 
Histol Histopathol, 25(2), 237-58. 
 
Núñez-Iglesias, M. J., Novío, S., Almeida-Dias, A. and Freire-Garabal, 
M. (2010) 'Inhibitory effects of alprazolam on the development of acute 
experimental autoimmune encephalomyelitis in stressed rats', 
Pharmacol Biochem Behav, 97(2), 350-6. 
 
Ortiz, J. B., Anglin, J. M., Daas, E. J., Paode, P. R., Nishimura, K. and 
Conrad, C. D. (2018) 'BDNF and TrkB Mediate the Improvement from 
Chronic Stress-induced Spatial Memory Deficits and CA3 Dendritic 
Retraction', Neuroscience, 388, 330-346. 
133 	
 
Ortiz, J. B., Mathewson, C. M., Hoffman, A. N., Hanavan, P. D., 
Terwilliger, E. F. and Conrad, C. D. (2014) 'Hippocampal brain-derived 
neurotrophic factor mediates recovery from chronic stress-induced 
spatial reference memory deficits', Eur J Neurosci, 40(9), 3351-62. 
 
Paré, W. P. and Glavin, G. B. (1986) 'Restraint stress in biomedical 
research: a review', Neurosci Biobehav Rev, 10(3), 339-70. 
 
Patki, G., Solanki, N., Atrooz, F., Allam, F. and Salim, S. (2013) 
'Depression, anxiety-like behavior and memory impairment are 
associated with increased oxidative stress and inflammation in a rat 
model of social stress', Brain Res, 1539, 73-86. 
 
Pechtel, P. and Pizzagalli, D. A. (2011) 'Effects of early life stress on 
cognitive and affective function: an integrated review of human 
literature', Psychopharmacology (Berl), 214(1), 55-70. 
 
Plath, N., Ohana, O., Dammermann, B., Errington, M. L., Schmitz, D., 
Gross, C., Mao, X., Engelsberg, A., Mahlke, C., Welzl, H., Kobalz, U., 
Stawrakakis, A., Fernandez, E., Waltereit, R., Bick-Sander, A., 
Therstappen, E., Cooke, S. F., Blanquet, V., Wurst, W., Salmen, B., 
Bösl, M. R., Lipp, H. P., Grant, S. G., Bliss, T. V., Wolfer, D. P. and 
Kuhl, D. (2006) 'Arc/Arg3.1 is essential for the consolidation of synaptic 
plasticity and memories', Neuron, 52(3), 437-44. 
 
Poo, M. M. (2001) 'Neurotrophins as synaptic modulators', Nat Rev 
Neurosci, 2(1), 24-32. 
 
Ragnedda, G., Leoni, S., Parpinel, M., Casetta, I., Riise, T., Myhr, K. M., 
Wolfson, C. and Pugliatti, M. (2015) 'Reduced duration of breastfeeding 
134 	
is associated with a higher risk of multiple sclerosis in both Italian and 
Norwegian adult males: the EnvIMS study', J Neurol, 262(5), 1271-7. 
 
Ramirez, K., Fornaguera-Trías, J. and Sheridan, J. F. (2017) 'Stress-
Induced Microglia Activation and Monocyte Trafficking to the Brain 
Underlie the Development of Anxiety and Depression', Curr Top Behav 
Neurosci, 31, 155-172. 
 
Reader, B. F., Jarrett, B. L., McKim, D. B., Wohleb, E. S., Godbout, J. 
P. and Sheridan, J. F. (2015a) 'Peripheral and central effects of 
repeated social defeat stress: monocyte trafficking, microglial activation, 
and anxiety', Neuroscience, 289, 429-42. 
 
Reader, B. F., Jarrett, B. L., McKim, D. B., Wohleb, E. S., Godbout, J. 
P. and Sheridan, J. F. (2015b) 'Peripheral and central effects of 
repeated social defeat stress: monocyte trafficking, microglial activation, 
and anxiety', Neuroscience, 289, 429-42. 
 
Riise, T., Mohr, D. C., Munger, K. L., Rich-Edwards, J. W., Kawachi, I. 
and Ascherio, A. (2011) 'Stress and the risk of multiple sclerosis', 
Neurology, 76(22), 1866-71. 
 
Robinson, A. P., Harp, C. T., Noronha, A. and Miller, S. D. (2014) 'The 
experimental autoimmune encephalomyelitis (EAE) model of MS: utility 
for understanding disease pathophysiology and treatment', Handb Clin 
Neurol, 122, 173-89. 
 
Rohleder, N. (2014) 'Stimulation of systemic low-grade inflammation by 
psychosocial stress', Psychosom Med, 76(3), 181-9. 
 
135 	
Romeo, R. D. (2013) 'The Teenage Brain: The Stress Response and 
the Adolescent Brain', Curr Dir Psychol Sci, 22(2), 140-145. 
 
Rossetti, A. C., Paladini, M. S., Colombo, M., Gruca, P., Lason-
Tyburkiewicz, M., Tota-Glowczyk, K., Papp, M., Riva, M. A. and Molteni, 
R. (2018) 'Chronic Stress Exposure Reduces Parvalbumin Expression 
in the Rat Hippocampus through an Imbalance of Redox Mechanisms: 
Restorative Effect of the Antipsychotic Lurasidone', Int J 
Neuropsychopharmacol, 21(9), 883-893. 
 
Rossetti, A. C., Papp, M., Gruca, P., Paladini, M. S., Racagni, G., Riva, 
M. A. and Molteni, R. (2016) 'Stress-induced anhedonia is associated 
with the activation of the inflammatory system in the rat brain: 
Restorative effect of pharmacological intervention', Pharmacol Res, 
103, 1-12. 
 
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., 
Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., 
Lebowitz, B. D., McGrath, P. J., Rosenbaum, J. F., Sackeim, H. A., 
Kupfer, D. J., Luther, J. and Fava, M. (2006) 'Acute and longer-term 
outcomes in depressed outpatients requiring one or several treatment 
steps: a STAR*D report', Am J Psychiatry, 163(11), 1905-17. 
 
Salehi, A., Rabiei, Z. and Setorki, M. (2018) 'Effect of gallic acid on 
chronic restraint stress-induced anxiety and memory loss in male 
BALB/c mice', Iran J Basic Med Sci, 21(12), 1232-1237. 
 
Salim, S. (2014) 'Oxidative stress and psychological disorders', Curr 
Neuropharmacol, 12(2), 140-7. 
 
136 	
Salleh, M. R. (2008) 'Life event, stress and illness', Malays J Med Sci, 
15(4), 9-18. 
 
Sapolsky, R. M., Romero, L. M. and Munck, A. U. (2000) 'How do 
glucocorticoids influence stress responses? Integrating permissive, 
suppressive, stimulatory, and preparative actions', Endocr Rev, 21(1), 
55-89. 
 
Sara, J. D., Prasad, M., Eleid, M. F., Zhang, M., Widmer, R. J. and 
Lerman, A. (2018) 'Association Between Work-Related Stress and 
Coronary Heart Disease: A Review of Prospective Studies Through the 
Job Strain, Effort-Reward Balance, and Organizational Justice Models', 
J Am Heart Assoc, 7(9). 
 
Schiavone, S., Jaquet, V., Trabace, L. and Krause, K. H. (2013) 'Severe 
life stress and oxidative stress in the brain: from animal models to 
human pathology', Antioxid Redox Signal, 18(12), 1475-90. 
 
Schmitt, A., Malchow, B., Hasan, A. and Falkai, P. (2014) 'The impact of 
environmental factors in severe psychiatric disorders', Front Neurosci, 
8, 19. 
 
Sharma, S., Powers, A., Bradley, B. and Ressler, K. J. (2016) 'Gene × 
Environment Determinants of Stress- and Anxiety-Related Disorders', 
Annu Rev Psychol, 67, 239-61. 
 
Shors, T. J. (2006) 'Stressful experience and learning across the 
lifespan', Annu Rev Psychol, 57, 55-85. 
 
Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., 
Przegaliński, E., Pera, J. and Filip, M. (2015) 'Oxidative stress as an 
137 	
etiological factor and a potential treatment target of psychiatric 
disorders. Part 2. Depression, anxiety, schizophrenia and autism', 
Pharmacol Rep, 67(3), 569-80. 
 
Solati, J., Asiaei, M. and Hoseini, M. H. (2012) 'Using experimental 
autoimmune encephalomyelitis as a model to study the effect of 
prenatal stress on fetal programming', Neurol Res, 34(5), 478-83. 
 
Song, C., Halbreich, U., Han, C., Leonard, B. E. and Luo, H. (2009) 
'Imbalance between pro- and anti-inflammatory cytokines, and between 
Th1 and Th2 cytokines in depressed patients: the effect of 
electroacupuncture or fluoxetine treatment', Pharmacopsychiatry, 42(5), 
182-8. 
 
Soriano, F. X., Léveillé, F., Papadia, S., Higgins, L. G., Varley, J., 
Baxter, P., Hayes, J. D. and Hardingham, G. E. (2008) 'Induction of 
sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation 
by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione', J 
Neurochem, 107(2), 533-43. 
 
Sotiropoulos, I. (2015) 'The neurodegenerative potential of chronic 
stress: a link between depression and Alzheimer's disease', Adv Exp 
Med Biol, 822, 221-2. 
 
Spiers, J. G., Chen, H. J., Cuffe, J. S., Sernia, C. and Lavidis, N. A. 
(2016) 'Acute restraint stress induces rapid changes in central redox 
status and protective antioxidant genes in rats', 
Psychoneuroendocrinology, 67, 104-12. 
 
Stein, D. J., Vasconcelos, M. F., Albrechet-Souza, L., Ceresér, K. M. M. 
and de Almeida, R. M. M. (2017) 'Microglial Over-Activation by Social 
138 	
Defeat Stress Contributes to Anxiety- and Depressive-Like Behaviors', 
Front Behav Neurosci, 11, 207. 
 
Sunico, C. R., Sultan, A., Nakamura, T., Dolatabadi, N., Parker, J., 
Shan, B., Han, X., Yates, J. R., Masliah, E., Ambasudhan, R., 
Nakanishi, N. and Lipton, S. A. (2016) 'Role of sulfiredoxin as a 
peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic 
neurons', Proc Natl Acad Sci U S A, 113(47), E7564-E7571. 
 
Teunis, M. A., Heijnen, C. J., Sluyter, F., Bakker, J. M., Van Dam, A. M., 
Hof, M., Cools, A. R. and Kavelaars, A. (2002) 'Maternal deprivation of 
rat pups increases clinical symptoms of experimental autoimmune 
encephalomyelitis at adult age', J Neuroimmunol, 133(1-2), 30-8. 
 
Tongiorgi, E. (2008) 'Activity-dependent expression of brain-derived 
neurotrophic factor in dendrites: facts and open questions', Neurosci 
Res, 61(4), 335-46. 
 
Tyler, W. A., Gangoli, N., Gokina, P., Kim, H. A., Covey, M., Levison, S. 
W. and Wood, T. L. (2009) 'Activation of the mammalian target of 
rapamycin (mTOR) is essential for oligodendrocyte differentiation', J 
Neurosci, 29(19), 6367-78. 
 
Tyler, W. A., Jain, M. R., Cifelli, S. E., Li, Q., Ku, L., Feng, Y., Li, H. and 
Wood, T. L. (2011) 'Proteomic identification of novel targets regulated 
by the mammalian target of rapamycin pathway during oligodendrocyte 
differentiation', Glia, 59(11), 1754-69. 
 
Voorhees, J. L., Tarr, A. J., Wohleb, E. S., Godbout, J. P., Mo, X., 
Sheridan, J. F., Eubank, T. D. and Marsh, C. B. (2013) 'Prolonged 
restraint stress increases IL-6, reduces IL-10, and causes persistent 
139 	
depressive-like behavior that is reversed by recombinant IL-10', PLoS 
One, 8(3), e58488. 
 
Vos, T., Haby, M. M., Barendregt, J. J., Kruijshaar, M., Corry, J. and 
Andrews, G. (2004) 'The burden of major depression avoidable by 
longer-term treatment strategies', Arch Gen Psychiatry, 61(11), 1097-
103. 
 
Wainstock, T., Anteby, E. Y., Glasser, S., Lerner-Geva, L. and Shoham-
Vardi, I. (2014) 'Exposure to life-threatening stressful situations and the 
risk of preterm birth and low birth weight', Int J Gynaecol Obstet, 125(1), 
28-32. 
 
Walhovd, K. B., Krogsrud, S. K., Amlien, I. K., Bartsch, H., Bjørnerud, 
A., Due-Tønnessen, P., Grydeland, H., Hagler, D. J., Håberg, A. K., 
Kremen, W. S., Ferschmann, L., Nyberg, L., Panizzon, M. S., Rohani, 
D. A., Skranes, J., Storsve, A. B., Sølsnes, A. E., Tamnes, C. K., 
Thompson, W. K., Reuter, C., Dale, A. M. and Fjell, A. M. (2016) 
'Neurodevelopmental origins of lifespan changes in brain and cognition', 
Proc Natl Acad Sci U S A, 113(33), 9357-62. 
 
Wang, F., Pan, F., Shapiro, L. A. and Huang, J. H. (2017) 'Stress 
Induced Neuroplasticity and Mental Disorders', Neural Plast, 2017, 
9634501. 
 
Wang, M., Ramasamy, V. S., Samidurai, M. and Jo, J. (2019) 'Acute 
restraint stress reverses impaired LTP in the hippocampal CA1 region in 
mouse models of Alzheimer's disease', Sci Rep, 9(1), 10955. 
 
Wang, Y. L., Han, Q. Q., Gong, W. Q., Pan, D. H., Wang, L. Z., Hu, W., 
Yang, M., Li, B., Yu, J. and Liu, Q. (2018) 'Microglial activation mediates 
140 	
chronic mild stress-induced depressive- and anxiety-like behavior in 
adult rats', J Neuroinflammation, 15(1), 21. 
 
Weber, M. D., Godbout, J. P. and Sheridan, J. F. (2017) 'Repeated 
Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the 
Signal', Neuropsychopharmacology, 42(1), 46-61. 
 
Weinstock, M. (2005) 'The potential influence of maternal stress 
hormones on development and mental health of the offspring', Brain 
Behav Immun, 19(4), 296-308. 
 
Weinstock, M. (2017) 'Prenatal stressors in rodents: Effects on 
behavior', Neurobiol Stress, 6, 3-13. 
 
Winiarski, D. A., Engel, M. L., Karnik, N. S. and Brennan, P. A. (2018) 
'Early Life Stress and Childhood Aggression: Mediating and Moderating 
Effects of Child Callousness and Stress Reactivity', Child Psychiatry 
Hum Dev, 49(5), 730-739. 
 
Winston, J. H., Li, Q. and Sarna, S. K. (2014) 'Chronic prenatal stress 
epigenetically modifies spinal cord BDNF expression to induce sex-
specific visceral hypersensitivity in offspring', Neurogastroenterol Motil, 
26(5), 715-30. 
 
Xia, B., Chen, C., Zhang, H., Xue, W., Tang, J., Tao, W., Wu, R., Ren, 
L., Wang, W. and Chen, G. (2016) 'Chronic stress prior to pregnancy 
potentiated long-lasting postpartum depressive-like behavior, regulated 
by Akt-mTOR signaling in the hippocampus', Sci Rep, 6, 35042. 
 
Yeh, C. M., Huang, C. C. and Hsu, K. S. (2012) 'Prenatal stress alters 
hippocampal synaptic plasticity in young rat offspring through 
141 	
preventing the proteolytic conversion of pro-brain-derived neurotrophic 
factor (BDNF) to mature BDNF', J Physiol, 590(4), 991-1010. 
 
Yoshii, A. and Constantine-Paton, M. (2010) 'Postsynaptic BDNF-TrkB 
signaling in synapse maturation, plasticity, and disease', Dev Neurobiol, 
70(5), 304-22. 
 
Young, E. E., Vichaya, E. G., Reusser, N. M., Cook, J. L., Steelman, A. 
J., Welsh, C. J. and Meagher, M. W. (2013) 'Chronic social stress 
impairs virus specific adaptive immunity during acute Theiler's virus 
infection', J Neuroimmunol, 254(1-2), 19-27. 
 
Zhang, Q., Wang, X., Bai, X., Xie, Y., Zhang, T., Bo, S. and Chen, X. 
(2017) 'Resveratrol reversed chronic restraint stress-induced impaired 
cognitive function in rats', Mol Med Rep, 16(2), 2095-2100. 
 
Zuccato, C. and Cattaneo, E. (2009) 'Brain-derived neurotrophic factor 
in neurodegenerative diseases', Nat Rev Neurol, 5(6), 311-22. 
 
Zucchi, F. C., Yao, Y., Ward, I. D., Ilnytskyy, Y., Olson, D. M., Benzies, 
K., Kovalchuk, I., Kovalchuk, O. and Metz, G. A. (2013) 'Maternal stress 
induces epigenetic signatures of psychiatric and neurological diseases 
in the offspring', PLoS One, 8(2), e56967. 
 
Ślusarczyk, J., Trojan, E., Głombik, K., Budziszewska, B., Kubera, M., 
Lasoń, W., Popiołek-Barczyk, K., Mika, J., Wędzony, K. and Basta-
Kaim, A. (2015) 'Prenatal stress is a vulnerability factor for altered 
morphology and biological activity of microglia cells', Front Cell 
Neurosci, 9, 82. 
 
 
